| Positive impact of oral hydroxychloroquine and povidone-iodine throat spray for COVID-19 prophylaxis: An open-label randomized trial 2021 · Vitamin C · Men aged 21–60 living in a high-exposure migrant-worker dormitory in Singapore, without known COVID-19 at enrollment | 500 mg | 6 weeks | 619 |
| Prospective randomized study of the vitamin C effect on pain and complex pain regional syndrome after total knee arthroplasty 2021 · vitamin C group · Patients after total knee arthroplasty | 1 g | 40 days | 153 |
| The efficacy of Helicobacter pylori eradication regimen with and without vitamin C supplementation 2009 · Group B · Patients with Helicobacter pylori infection; age and sex not reported | 500 mg | 2 weeks | 150 |
| Vitamin C prevention of complex regional pain syndrome after foot and ankle surgery: a prospective randomized study of three hundred and twenty nine patients 2021 · vitamin C group · Patients undergoing foot or ankle surgery for trauma or elective reasons | 1 g | 40 days | 121 |
| Can vitamin C prevent complex regional pain syndrome in patients with wrist fractures? A randomized, controlled, multicenter dose-response study 2007 · 500-mg group · Patients with wrist fractures; age range and sex not specified | 500 mg | 50 days | 114 |
| Intermittent preventive treatment using artemisinin-based combination therapy reduces malaria morbidity among school-aged children in Mali 2009 · Arm C (vitamin C) · Children aged 6–13 years attending school in Kollé, Mali, without severe acute illness or chronic disease | 250 mg | 3 days | 98 |
| Adjuvant effect of vitamin C on omeprazole-amoxicillin-clarithromycin triple therapy for Helicobacter pylori eradication 2007 · V-C250 group · H. pylori-infected patients with clarithromycin-susceptible or clarithromycin-resistant infection; age and sex not stated | 1 g | 7 days | 61 |
| Effect of vitamin C on frequency of reflex sympathetic dystrophy in wrist fractures: a randomised trial 1999 · vitamin C group · Adults with conservatively treated wrist fractures; mean age 57 years | 500 mg | 50 days | 52 |
| Possible prevention of postangioplasty restenosis by ascorbic acid 1996 · ascorbic acid group · Patients after percutaneous transluminal coronary angioplasty (PTCA) | 500 mg | — | 50 |
| Ascorbic acid and intestinal metaplasia in the stomach: a prospective, randomized study 2000 · ascorbic acid group · Patients with gastric intestinal metaplasia after H. pylori eradication | 500 mg | 26 weeks | 32 |
| The Effect of Vitamin C on Pathological Parameters and Survival Duration of Critically Ill Coronavirus Disease 2019 Patients: A Randomized Clinical Trial 2021 · vitamin C supplementation group · Critically ill adults aged 35–75 with COVID-19, admitted to the ICU and requiring enteral nutrition | 500 mg | 2 weeks | 31 |
| Role of reactive oxygen metabolites in aspirin-induced gastric damage in humans: gastroprotection by vitamin C 2001 · aspirin with vitamin C · Human volunteers; age, sex, and health condition not specified | 960 mg | 3 days | — |
| A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study 2007 · Vitamin C group · Women aged 40 years or older with a history of cardiovascular disease or at least three cardiovascular risk factors | 500 mg | 3431 days | — |
| The effect of vitamin C on upper respiratory infections in adolescent swimmers: a randomized trial 2011 · Vitamin C group · Competitive adolescent swimmers; mean age 13.8 ± 1.6 years, male and female, in Jerusalem | 1 g | 90 days | — |
| Effects of vitamin C supplementation on gout risk: results from the Physicians' Health Study II trial 2022 · vitamin C assignment · Male physicians; mean age 64 ± 9 years | 500 mg | 10 years | — |
| Can vitamin C prevent complex regional pain syndrome in patients with wrist fractures? A randomized, controlled, multicenter dose-response study 2007 · 1500-mg group · Patients with wrist fractures; age range and sex not specified | 1.5 g | 50 days | 118 |
| Can vitamin C prevent complex regional pain syndrome in patients with wrist fractures? A randomized, controlled, multicenter dose-response study 2007 · 200-mg group · Patients with wrist fractures; age range and sex not specified | 200 mg | 50 days | 96 |
| Effect of allopurinol, sulphasalazine, and vitamin C on aspirin induced gastroduodenal injury in human volunteers 1996 · vitamin C · Healthy volunteers, mean age 27 years (range 20–40), seven male | 2 g | 3 days | 14 |
| Effect of vitamin C on common cold: randomized controlled trial 2006 · high-dose group · Participants in annual screening programs in a village in Akita prefecture who were diagnosed with atrophic gastritis; age and sex not stated | 500 mg | 5 years | 161 |
| Oral Vitamin C (500 mg/d) to Pregnant Smokers Improves Infant Airway Function at 3 Months (VCSIP). A Randomized Trial 2019 · vitamin C · Pregnant smokers randomized at 13–23 weeks of gestation | 500 mg | — | 125 |
| Effect of Vitamin C Supplementation for Pregnant Smokers on Offspring Airway Function and Wheeze at Age 5 Years: Follow-up of a Randomized Clinical Trial 2023 · vitamin C · Pregnant smokers | 500 mg | — | 125 |
| Vitamin C supplementation for pregnant smoking women and pulmonary function in their newborn infants: a randomized clinical trial 2014 · vitamin C group · Pregnant smokers aged 15 years or older, with a singleton pregnancy, randomized by 22 weeks’ gestation | 500 mg | — | 89 |
| Spirometry Versus Forced Oscillation to Assess Lung Function Outcome at 5 Years of Age 2025 · Vitamin C · Pregnant smokers who continued smoking during pregnancy; offspring followed to 5 years of age | 500 mg | — | 73 |
| Vitamin C demand is increased after total knee arthroplasty: a double-blind placebo-controlled-randomized study 2019 · VC group · Patients undergoing total knee arthroplasty; age and sex not stated | 1 g | 50 days | 48 |
| The effect of adjuvant vitamin C after varicocele surgery on sperm quality and quantity in infertile men: a double blind placebo controlled clinical trial 2015 · vitamin C (intervention) group · Infertile men aged 18–50 with palpable grade 2 or 3 varicocele and abnormal semen parameters, after varicocele surgery | 500 mg | 90 days | 46 |
| Randomised double-blind trial of the effect of vitamin C on dyspareunia and vaginal discharge in women receiving doxycycline and triple sulfa for chlamydial cervicitis 2009 · doxycycline, triple sulfa plus vitamin C · women with chlamydial cervicitis, reporting abnormal vaginal discharge and dyspareunia | 250 mg | 10 days | 41 |
| A Pilot of a Randomized Control Trial of Melatonin and Vitamin C for Mild-to-Moderate COVID-19 2022 · vitamin C · Patients with mild-to-moderate COVID-19 symptoms | 1 g | 2 weeks | 32 |
| Vitamin C supplementation improves placental function and alters placental gene expression in smokers 2024 · Vitamin C-treated smokers · Pregnant women aged 15 years or older with singleton pregnancies, currently smoking and unable or unwilling to quit | 500 mg | — | 29 |
| Vitamin C supplementation promotes mental vitality in healthy young adults: results from a cross-sectional analysis and a randomized, double-blind, placebo-controlled trial 2022 · vitamin C supplementation group · Men and women aged 20–39 with inadequate vitamin C status (serum concentration below 50 μmol/L) and no acute or chronic disease | 1 g | 4 weeks | 25 |
| Oral vitamin C and endothelial function in smokers: short-term improvement, but no sustained beneficial effect 2000 · 8-week vitamin C phase · Healthy young adult smokers, age 36 ± 6 years; 8 male participants | 1 g | 8 weeks | 20 |
| Effects of a 'healthy' diet and of acute and long-term vitamin C on vascular function in healthy older subjects 2002 · oral vitamin C · Healthy adults aged 57–80 years | 1 g | 6 weeks | 18 |
| A randomized, double-blind, placebo-controlled trial of supplementary vitamins E, C and their combination for treatment of haemodialysis cramps 2001 · vitamin C · haemodialysis patients with end-stage renal disease; age and sex not specified | 250 mg | 8 weeks | 15 |
| Vitamin C supplementation slightly improves physical activity levels and reduces cold incidence in men with marginal vitamin C status: a randomized controlled trial 2014 · vitamin C group · Men aged 18–35 with plasma vitamin C below 45 µmol/L; apparently healthy, nonsmoking, and not training for competitive sports | 1 g | 8 weeks | 15 |
| Effect of ascorbic acid supplementation on pulmonary functions in healthy adults: a randomized controlled pilot study 2022 · AA250 arm · Healthy adults aged 35 years or older | 250 mg | 6 weeks | 15 |
| Effect of ascorbic acid supplementation on pulmonary functions in healthy adults: a randomized controlled pilot study 2022 · AA500 arm · Healthy adults aged 35 years or older | 500 mg | 6 weeks | 15 |
| Efficacy of vitamin C as an adjunct to fluoxetine therapy in pediatric major depressive disorder: a randomized, double-blind, placebo-controlled pilot study 2013 · vitamin C group · Children and adolescents aged 7–14 with major depressive disorder receiving fluoxetine | 1 g | 26 weeks | 14 |
| Oral vitamin C treatment increases polymorphonuclear cell functions in type 2 diabetes mellitus patients with poor glycemic control 2020 · vitamin C · Patients with type 2 diabetes mellitus and poor glycemic control | 1 g | 6 weeks | 14 |
| Effect of antioxidant vitamin supplementation on muscle function after eccentric exercise 1993 · vitamin C · physically active young subjects | 400 mg | 4 weeks | 8 |
| Plasma vitamin C is inversely related to body mass index and waist circumference but not to plasma adiponectin in nonsmoking adults 2007 · vitamin C · Obese men and women; age and sex breakdown not reported | 500 mg | 8 weeks | 6 |
| Assessment of the Effect of Intestinal Permeability Probes (Lactulose And Mannitol) and Other Liquids on Digesta Residence Times in Various Segments of the Gut Determined by Wireless Motility Capsule: A Randomised Controlled Trial 2015 · Ascorbic acid · Healthy women aged 20–40 years | 500 mg | 1 day | 6 |
| Vitamin C supplementation in patients with hypothyroidism requiring high-dose levothyroxine: a proof-of-concept pilot study 2025 · Treatment Group · Adults aged 18 years or older with autoimmune primary hypothyroidism taking levothyroxine above 1.6 µg/kg/day | 1 g | 16 weeks | 6 |
| Oral administration of vitamin C decreases muscle mitochondrial biogenesis and hampers training-induced adaptations in endurance performance 2008 · Vitamin C group · Men aged 27–36 years undergoing endurance training | 1 g | 8 weeks | 5 |
| Blocking effect of vitamin C in exercise-induced asthma 1997 · continued ascorbic acid · Patients aged 7–28 years with exercise-induced asthma who had shown a protective response to ascorbic acid | 500 mg | 2 weeks | 4 |
| Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease 1999 · long-term ascorbic acid treatment · Patients with angiographically established coronary artery disease; age and sex not reported | 500 mg | 30 days | — |
| Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis 2000 · vitamin C · Smoking and nonsmoking men and postmenopausal women aged 45–69 years with serum cholesterol ≥5.0 mmol/L | 500 mg | 3 years | — |
| [Reduced pain from osteoarthritis in hip joint or knee joint during treatment with calcium ascorbate. A randomized, placebo-controlled cross-over trial in general practice] 2003 · calcium ascorbate · Patients with radiographically verified symptomatic osteoarthritis of the hip and/or knee joints; age and sex not stated | 1 g | 2 weeks | — |
| The release of vitamin C from chewing gum and its effects on supragingival calculus formation 2005 · vitamin C gum (Series I) · Calculus-forming subjects; age and sex not reported | 300 mg | 90 days | — |
| L-arginine improves endothelial function and reduces LDL oxidation in patients with stable coronary artery disease 2005 · vitamin C active control · Adults with stable coronary artery disease | 500 mg | 4 weeks | — |
| Vitamin E, vitamin C, beta carotene, and cognitive function among women with or at risk of cardiovascular disease: The Women's Antioxidant and Cardiovascular Study 2009 · Vitamin C group · Women aged 65 years or older in the cognitive substudy, with cardiovascular disease or at least three coronary risk factors | 500 mg | 3249 days | — |
| Vitamin C provision improves mood in acutely hospitalized patients 2011 · Vitamin C · Acutely hospitalized patients with hypovitaminosis C | 1 g | — | — |
| Vitamin C status and perception of effort during exercise in obese adults adhering to a calorie-reduced diet 2013 · vitamin C (VC) · Healthy obese adults adhering to a vitamin C-controlled, calorie-restricted diet; 20 adults were enrolled, but the number in this arm is not stated. | 500 mg | 4 weeks | — |
| A short-term evaluation of the relationship between plasma ascorbic acid levels and periodontal disease in systemically healthy and type 2 diabetes mellitus subjects 2013 · Group 2: chronic gingivitis, SRP with dietary ascorbic acid supplementation · People with chronic gingivitis; age and sex not reported | 450 mg | 2 weeks | — |
| A short-term evaluation of the relationship between plasma ascorbic acid levels and periodontal disease in systemically healthy and type 2 diabetes mellitus subjects 2013 · Group 3: chronic periodontitis, SRP with dietary ascorbic acid supplementation · People with chronic periodontitis; age and sex not reported | 450 mg | 2 weeks | — |
| A short-term evaluation of the relationship between plasma ascorbic acid levels and periodontal disease in systemically healthy and type 2 diabetes mellitus subjects 2013 · Group 4: chronic periodontitis and freshly diagnosed T2DM, SRP with dietary ascorbic acid supplementation · People with chronic periodontitis and freshly diagnosed type 2 diabetes mellitus; age and sex not reported | 450 mg | 2 weeks | — |
| Effects of vitamin C and vitamin D administration on mood and distress in acutely hospitalized patients 2013 · vitamin C · Acutely hospitalized patients with a high prevalence of hypovitaminosis C and D | 1 g | 8 days | — |
| Efficacy of supplementary vitamins C and E on anxiety, depression and stress in type 2 diabetic patients: a randomized, single-blind, placebo-controlled trial 2013 · vitamin C group · Adults with type 2 diabetes; age and sex not specified | 1 g | 6 weeks | — |
| Effects of Oral Vitamin C Supplementation on Anxiety in Students: A Double-Blind, Randomized, Placebo-Controlled Trial 2015 · vitamin C group · High school students; age and sex not reported; anxiety status not specified | 500 mg | 2 weeks | — |
| Comparing the Effectiveness of Dietary Vitamin C and Exercise Interventions on Fertility Parameters in Normal Obese Men 2016 · vitamin C group · Men across BMI categories, including normal-weight, overweight and obese men | 500 mg | 26 weeks | — |
| Effects of ascorbic acid on anxiety state and affect in a non-clinical sample 2017 · ascorbic acid · Graduate students, mainly healthy young women; a subgroup comprised more anxious healthy women | 1 g | 1 day | — |
| KiwiC for Vitality: Results of a Randomized Placebo-Controlled Trial Testing the Effects of Kiwifruit or Vitamin C Tablets on Vitality in Adults with Low Vitamin C Levels 2020 · vitamin C condition · Healthy young adults with low baseline plasma vitamin C levels; men and women, young-adult age range not specified | 250 mg | 4 weeks | — |
| Vitamin C supplementation reduces the incidence of postrace symptoms of upper-respiratory-tract infection in ultramarathon runners 1993 · vitamin C-supplemented ultramarathon runners · Ultramarathon runners; age and sex not reported | 600 mg | — | — |
| Vitamin C supplementation reduces the incidence of postrace symptoms of upper-respiratory-tract infection in ultramarathon runners 1993 · vitamin C-supplemented nonrunning controls · Nonrunning controls; age and sex not reported | 600 mg | — | — |
| Vitamin C supplementation reduces the odds of developing a common cold in Republic of Korea Army recruits: randomised controlled trial 2022 · vitamin C group · Republic of Korea Army recruits enlisted at the Korea Army Training Centre | 6 g | 30 days | 695 |
| Positive impact of oral hydroxychloroquine and povidone-iodine throat spray for COVID-19 prophylaxis: An open-label randomized trial 2021 · Zinc & vitamin C · Men aged 21–60 living in a high-exposure migrant-worker dormitory in Singapore, without known COVID-19 at enrollment | 500 mg | 6 weeks | 634 |
| Vitamin C supplementation to prevent premature rupture of the chorioamniotic membranes: a randomized trial 2005 · vitamin C group · pregnant women in their 20th week of gestation | 100 mg | 16 weeks | 52 |
| [Efficacy and safety of vitamin D in the treatment of idiopathic oligoasthenozoospermia] 2014 · control group · Men with idiopathic oligoasthenozoospermia | 300 mg | 90 days | 43 |
| Effects of high dose vitamin C treatment on Helicobacter pylori infection and total vitamin C concentration in gastric juice 1998 · Group 2 (vitamin C) · Patients with dyspeptic symptoms, chronic gastritis and H. pylori infection; age and sex not reported | 5 g | 4 weeks | 32 |
| Beneficial therapeutic effects of vitamin C on recurrent respiratory tract infections in children: preliminary data 2021 · group at risk of recurrent RTIs (G2) · children with recurrent respiratory tract infections | 70 mg | — | 27 |
| Impact of ascorbic acid in reducing the incidence of vancomycin associated nephrotoxicity in critically ill patients: A preliminary randomized controlled trial 2021 · vancomycin-ascorbic acid (intervention) group · critically ill adults over 18 of both sexes with suspected or confirmed MRSA infection requiring vancomycin | 4 g | 7 days | 21 |
| [A controlled randomized trial of the use of combined L-carnitine and acetyl-L-carnitine treatment in men with oligoasthenozoospermia] 2005 · control group · men with oligoasthenozoospermia | 300 mg | 90 days | — |
| Role of Oral Vitamin 'C' on Astigmatic Errors in Phacoemulsification 2020 · Group A · Patients undergoing cataract surgery; age and sex not reported | 1.5 g | 6 weeks | 200 |
| Echinacea reduces antibiotic usage in children through respiratory tract infection prevention: a randomized, blinded, controlled clinical trial 2021 · Vitamin C group (VC; reference/control) · Healthy children aged 4–12 years | 150 mg | 120 days | 98 |
| Impact of oral vitamin C on histamine levels and seasickness 2014 · vitamin C · Adult volunteers exposed to waves in a life raft; age and sex range not stated | 2 g | 1 day | 63 |
| Comparison of the effects of preoperative melatonin or vitamin C administration on postoperative analgesia 2020 · group C (vitamin C group) · Adults aged 18–65 years, ASA status I–II, undergoing elective major abdominal surgery | 2 g | 1 day | 55 |
| Does vitamin C or its combination with vitamin E improve radial artery endothelium-dependent vasodilatation in patients awaiting coronary artery bypass surgery? 2013 · vitamin C group (group 1) · Adults with angiographically confirmed significant coronary artery disease awaiting coronary artery bypass surgery | 2 g | 1 day | 31 |
| Effect of ascorbic acid on forearm reactive hyperaemia in patients with hypercholesterolaemia 2004 · Group A · Adults with hypercholesterolaemia; ages and sex are not reported | 2 g | 1 day | 25 |
| Improvement of sympathetic response to exercise by oral administration of ascorbic acid in patients after myocardial infarction 2006 · ascorbic acid · 21 male patients after myocardial infarction | 2 g | 1 day | 21 |
| Oral vitamin C and endothelial function in smokers: short-term improvement, but no sustained beneficial effect 2000 · single-dose vitamin C phase · Healthy young adult smokers, age 36 ± 6 years; 8 male participants | 2 g | 1 day | 20 |
| Blocking effect of vitamin C in exercise-induced asthma 1997 · ascorbic acid · Patients aged 7–28 years with exercise-induced asthma | 2 g | 1 day | 20 |
| Efficacy of vitamins C, E, and their combination for treatment of restless legs syndrome in hemodialysis patients: a randomized, double-blind, placebo-controlled trial 2012 · vitamin C (200 mg) and placebo · Hemodialysis patients with restless legs syndrome | 200 mg | 8 weeks | 15 |
| Differential influence of vitamin C on the peripheral and cerebral circulation after diving and exposure to hyperoxia 2018 · vitamin C trial · Divers; age and sex not reported; participants performed scuba diving and a follow-up hyperoxia exposure | 2 g | 6 days | 14 |
| Acute mountain sickness; prophylactic benefits of antioxidant vitamin supplementation at high altitude 2001 · antioxidant group · Adults aged 35 ± 10 years ascending to high altitude; no diagnosed condition reported | 1 g | 31 days | 9 |
| Ascorbic acid supplementation attenuates exercise-induced bronchoconstriction in patients with asthma 2007 · ascorbic acid supplementation · Eight asthmatic subjects with documented exercise-induced bronchoconstriction; age and sex not reported | 1.5 g | 2 weeks | 8 |
| Effect of nighttime aircraft noise exposure on endothelial function and stress hormone release in healthy adults 2013 · Vitamin C challenge · Healthy adults aged 20–60 exposed to Noise60; five control subjects received vitamin C | 2 g | 1 day | 5 |
| Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease 1999 · single-dose ascorbic acid treatment · Patients with angiographically established coronary artery disease; age and sex not reported | 2 g | 1 day | — |
| Oral vitamin C reduces arterial stiffness and platelet aggregation in humans 1999 · vitamin C · healthy male volunteers | 2 g | 1 day | — |
| Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis 2000 · combination of vitamins E and C · Smoking and nonsmoking men and postmenopausal women aged 45–69 years with serum cholesterol ≥5.0 mmol/L | 500 mg | 3 years | — |
| Vitamin C improves endothelial dysfunction in renal allograft recipients 2001 · vitamin C · renal allograft recipients | 2 g | 1 day | — |
| Effect of antioxidant supplementation on ozone-induced lung injury in human subjects 2001 · supplemented cohort · Healthy nonsmoking adults aged 18 to 35 years | 250 mg | 2 weeks | — |
| UVB photoprotection with antioxidants: effects of oral therapy with d-alpha-tocopherol and ascorbic acid on the minimal erythema dose 2002 · Group 2 · Healthy volunteers | 2 g | 7 days | — |
| The release of vitamin C from chewing gum and its effects on supragingival calculus formation 2005 · vitamin C + carbamide gum (Series II) · Calculus-forming subjects; age and sex not reported | 300 mg | 90 days | — |
| Oral vitamin C enhances the adrenergic vasoconstrictor response to local cooling in human skin 2012 · oral Asc (ascorbic acid) · Humans; age, sex, and health condition not specified | 2 g | 1 day | — |
| Effect of vitamin C on morphine use after laparoscopic cholecystectomy: a randomized controlled trial 2012 · vitamin C group · Adults undergoing laparoscopic cholecystectomy | 2 g | 1 day | — |
| Ozone exposure, vitamin C intake, and genetic susceptibility of asthmatic children in Mexico City: a cohort study 2013 · supplementation group · Asthmatic children recruited at Hospital Infantil Federico Gómez in Mexico City; ages 7–11 years represented in the analysed sample | 250 mg | 12 weeks | — |
| Vitamin C and E supplementation hampers cellular adaptation to endurance training in humans: a double-blind, randomised, controlled trial 2014 · vitamin C and E group · young men and women undergoing endurance training; age range and health condition not stated | 1 g | 11 weeks | — |
| Vitamin C and E supplementation blunts increases in total lean body mass in elderly men after strength training 2016 · antioxidant group · Men aged 60–81 years participating in strength training | 1 g | 12 weeks | — |
| The clinical effects of vitamin C supplementation in elderly hospitalised patients with acute respiratory infections 1994 · vitamin C · elderly hospitalised patients with acute respiratory infections, including bronchitis and bronchopneumonia; sex not specified | 200 mg | 4 weeks | — |
| Effect of vitamin C on ambulatory blood pressure and plasma lipids in older persons 2000 · Vitamin C · Men and women aged 60–80 years | 500 mg | 90 days | 40 |
| Effect of ascorbate on serum lipids and urate metabolism during exhaustive training 2004 · ascorbate group · well-trained male athletes undergoing exhaustive training | 1 g | 3 weeks | 4 |
| Ascorbic acid reduces blood pressure and arterial stiffness in type 2 diabetes 2002 · ascorbic acid · Adults aged 45–70 with type 2 diabetes | 500 mg | 4 weeks | — |
| The combination of vitamin C and grape-seed polyphenols increases blood pressure: a randomized, double-blind, placebo-controlled trial 2005 · vitamin C alone · Treated hypertensive individuals with mean 24-hour ambulatory systolic blood pressure ≥125 mmHg | 500 mg | 6 weeks | — |
| Effects of high-dose B vitamin complex with vitamin C and minerals on subjective mood and performance in healthy males 2010 · multi-vitamin/mineral · Healthy males aged 30–55 years in full-time employment | 500 mg | 33 days | 103 |
| Prenatal vitamin C and E supplementation in smokers is associated with reduced placental abruption and preterm birth: a secondary analysis 2015 · Vitamin C and E supplementation · Pregnant low-risk nulliparous women with singleton gestations; the reported subgroup analysis included women who smoked during pregnancy | 1 g | — | 4,993 |
| Vitamin C and E supplementation to prevent spontaneous preterm birth: a randomized controlled trial 2010 · vitamin C and E supplementation · Low-risk nulliparous women with singleton pregnancies, enrolled at 9 weeks 0 days to 16 weeks 6 days of gestation | 1 g | — | 4,992 |
| Impact of iron fortification on anaemia and iron deficiency among pre-school children living in Rural Ghana 2021 · non-iron MNP group · Children aged 6–35 months living in rural Ghana; children with severe anaemia, severe malnutrition, recent iron supplementation, or chronic disease were excluded. | 30 mg | 150 days | 991 |
| Supplementing vitamins C and E to standard triple therapy for the eradication of Helicobacter pylori 2012 · Group A · Patients with Helicobacter pylori infection | 1 g | 30 days | 160 |
| Supplementing vitamins C and E to standard triple therapy for the eradication of Helicobacter pylori 2012 · Group A · Patients with Helicobacter pylori infection | 1 g | 30 days | 160 |
| Randomized control trial comparing effectiveness of weekly versus daily antenatal oral iron supplementation in preventing anemia during pregnancy 2018 · weekly supplementation group · Non-anemic pregnant women at 14–22 weeks’ gestation | 14.3 mg | — | 149 |
| Randomized control trial comparing effectiveness of weekly versus daily antenatal oral iron supplementation in preventing anemia during pregnancy 2018 · daily supplementation group · Non-anemic pregnant women at 14–22 weeks’ gestation | 100 mg | — | 143 |
| Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial 1999 · vitamin group · Women at increased risk of pre-eclampsia, enrolled at 16–22 weeks’ gestation | 1 g | — | 141 |
| A randomized controlled trial to prevent post-operative atrial fibrillation by antioxidant reinforcement 2013 · supplemented group · Patients scheduled for on-pump cardiac surgery; age and sex not specified | 1 g | — | 103 |
| Oxidative stress in Helicobacter pylori infection: does supplementation with vitamins C and E increase the eradication rate? 2009 · group B · Patients with Helicobacter pylori infection; age range and sex not reported | 1 g | 30 days | 80 |
| Efficacy of vitamins supplementation to therapy on Helicobacter pylori eradication in patients with low antioxidant capacity 2011 · Group A · Patients with H. pylori-positive nonulcer dyspepsia, chronic stress, and low total antioxidant capacity | 1 g | 30 days | 80 |
| The Influence of High-Dose Parenteral Vitamin C on the Incidence and Severity of Postoperative Pulmonary Complications in Cardiac Surgery with Extracorporeal Circulation: A Randomized Controlled Trial 2024 · Intervention group (B) · Adults aged 18 years or older undergoing elective cardiac surgery with extracorporeal circulation | 2 g | — | 75 |
| Oral ascorbic acid in combination with beta-blockers is more effective than beta-blockers alone in the prevention of atrial fibrillation after coronary artery bypass grafting 2007 · ascorbic acid group · Adults older than 50 years scheduled for coronary artery bypass grafting and treated with beta-blockers for at least 1 week before surgery | 2 g | 6 days | 50 |
| Effect of oral vitamin C on atrial fibrillation development after isolated coronary artery bypass grafting surgery: A prospective randomized clinical trial 2014 · Group 1 · Adults undergoing elective isolated on-pump coronary artery bypass grafting surgery; mean age 61.31 ± 6.42 years; sex not reported | 1 g | 5 days | 50 |
| N-acetylcysteine and/or ascorbic acid versus placebo to prevent contrast-induced nephropathy in patients undergoing elective cardiac catheterization: The NAPCIN trial; A single-center, prospective, randomized trial 2016 · Group B · High-risk patients undergoing elective cardiac catheterization | 7 g | — | 30 |
| MRC/BHF Heart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience 1999 · antioxidant vitamin supplement · Men and women aged 40–80 at elevated risk of coronary heart disease death due to prior coronary heart disease, occlusive non-coronary arterial disease, diabetes mellitus, or treated hypertension | 250 mg | 5 years | — |
| A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8 2001 · Antioxidants · Adults aged 55–80 with age-related macular degeneration Categories 2–4 and visual acuity of 20/32 or better in at least one eye | 500 mg | 8 years | — |
| Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13 2004 · antioxidants alone · Adults aged 55–81 years with age-related macular degeneration categories 1–4 or other AREDS ocular eligibility; participants in AMD categories 2–4 were eligible for this arm, and category 1 participants could also receive antioxidants | 500 mg | 339 weeks | — |
| Vitamins C and E in the latency period in women with preterm premature rupture of membranes 2005 · vitamin C and vitamin E · Women with singleton pregnancies at 26 to 34 weeks' gestation and PPROM | 500 mg | — | — |
| Antioxidant effects of combined vitamins C and E in acute myocardial infarction. The randomized, double-blind, placebo controlled, multicenter pilot Myocardial Infarction and VITamins (MIVIT) trial 2005 · antioxidant vitamins · Adults with acute myocardial infarction; mean age 62 years | 1.2 g | 30 days | — |
| Fortifying milk with ferrous gluconate and zinc oxide in a public nutrition program reduced the prevalence of anemia in toddlers 2006 · Fortified milk (FM) · Healthy, low-income children aged 10–30 months | 48 mg | 26 weeks | — |
| Daily intake of 100 mg ascorbic acid as urinary tract infection prophylactic agent during pregnancy 2007 · Group A · Pregnant women | 100 mg | 90 days | — |
| Atorvastatin and antioxidants for the treatment of nonalcoholic fatty liver disease: the St Francis Heart Study randomized clinical trial 2011 · daily combination of atorvastatin, vitamin C, and vitamin E · Men and women aged 50–70 years; healthy individuals, including a subgroup with NAFLD at baseline | 1 g | 1314 days | — |
| Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35 2013 · Antioxidants · Adults aged 55–80 with age-related macular degeneration (AREDS categories 1–4) | 500 mg | 339 weeks | — |
| No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38 2014 · antioxidants · Adults with intermediate age-related macular degeneration in one or both eyes or late age-related macular degeneration in one eye; mean age 69 years | 500 mg | 9 years | — |
| Investigating the preventive effect of vitamins C and E on preeclampsia in nulliparous pregnant women 2020 · intervention group · Nulliparous pregnant women aged 18–38 years without risk factors for preeclampsia | 1 g | — | — |
| Antioxidant vitamins or lactulose for the prevention of the recurrence of colorectal adenomas. Colorectal Cancer Study Group of the University of Modena and the Health Care District 16 1993 · Group 1 (vitamins) · Individuals after endoscopic polypectomy; age and sex not reported; adenomas were the condition of interest. | 1 g | 548 days | — |
| Effect of micronutrient supplementation on infection in institutionalized elderly subjects: a controlled trial 1997 · vitamins · Institutionalized elderly subjects in a geriatric center; low serum vitamin C was common at baseline | 120 mg | 2 years | — |
| Effect of vitamin C on common cold: randomized controlled trial 2006 · low-dose group · Participants in annual screening programs in a village in Akita prefecture who were diagnosed with atrophic gastritis; age and sex not stated | 50 mg | 5 years | 144 |
| Bowel Preparation Efficacy and Safety of 1 L vs 2 L Polyethylene Glycol With Ascorbic Acid for Colonoscopy: A Randomized Controlled Trial 2023 · 2 L-PEG/Asc group · Adults aged 19–85 undergoing elective colonoscopy for symptoms, screening, or surveillance | 21.2 g | 1 day | 120 |
| Bowel Preparation Efficacy and Safety of 1 L vs 2 L Polyethylene Glycol With Ascorbic Acid for Colonoscopy: A Randomized Controlled Trial 2023 · 1 L-PEG/Asc group · Adults aged 19–85 undergoing elective colonoscopy for symptoms, screening, or surveillance | 50 g | 1 day | 120 |
| A randomized controlled trial of high dose ascorbic acid for reduction of blood pressure, cortisol, and subjective responses to psychological stress 2002 · ascorbic acid group · healthy young adults; age range and sex not reported | 3 g | 2 weeks | 60 |
| High-dose ascorbic acid increases intercourse frequency and improves mood: a randomized controlled clinical trial 2002 · Ascorbic acid group · Healthy young adults aged not specified | 3 g | 2 weeks | 42 |
| Novel 1 L polyethylene glycol-based bowel preparation (NER1006): proof of concept assessment versus standard 2 L polyethylene glycol with ascorbate - a randomized, parallel group, phase 2, colonoscopist-blinded trial 2019 · LVPEG-5 (Part 2) · Adults aged 40–70 years at known personal or familial colorectal cancer risk, or aged 55–70 years, undergoing screening colonoscopy | 40 g | 2 days | 30 |
| Effects of vitamins C and E supplementation combined with 12-week resistance training in older women with sarcopenia: A randomized, double-blind, placebo-controlled trial 2025 · Antioxidant supplementation group (AS) · Women aged 60–75 with sarcopenia; all participants had inadequate baseline vitamin C status, and most had inadequate vitamin E status. | 1 g | 12 weeks | 30 |
| Randomized, double-blind, placebo-controlled study of the preventive effect of supplemental oral vitamin C on attenuation of development of nitrate tolerance 1998 · vitamin C group · Normal volunteers and patients with ischemic heart disease | 6 g | 6 days | 24 |
| Double-blind intervention trial on modulation of ozone effects on pulmonary function by antioxidant supplements 1999 · vitamin group · Dutch bicyclists; adults, with no stated medical condition, studied during exercise in ozone exposure | 500 mg | 15 weeks | 20 |
| A randomized, double-blind, placebo-controlled trial of supplementary vitamins E, C and their combination for treatment of haemodialysis cramps 2001 · combination of vitamins E and C · haemodialysis patients with end-stage renal disease; age and sex not specified | 250 mg | 8 weeks | 15 |
| Efficacy of vitamins C, E, and their combination for treatment of restless legs syndrome in hemodialysis patients: a randomized, double-blind, placebo-controlled trial 2012 · vitamin C (200 mg) and vitamin E (400 mg) · Hemodialysis patients with restless legs syndrome | 200 mg | 8 weeks | 15 |
| Attenuation of angiotensin converting enzyme inhibitor induced cough by iron supplementation: role of nitric oxide 2011 · anti-oxidant group · Patients with cough while receiving ACE-inhibitor therapy; age and sex not reported | 150 mg | 4 weeks | 8 |
| Role of nitric oxide and oxidative stress in baroreceptor dysfunction in patients with chronic heart failure 2003 · CHF patients receiving oral vitamin C · Adults with chronic heart failure | 4 g | 4 weeks | — |
| Comparative effects of enzogenol and vitamin C supplementation versus vitamin C alone on endothelial function and biochemical markers of oxidative stress and inflammation in chronic smokers 2006 · Vitamin C alone · Chronic smokers without established cardiovascular disease | 60 mg | 12 weeks | — |
| Coenzyme Q10 supplementation reduces corticosteroids dosage in patients with bronchial asthma 2005 · Antioxidants in addition to standard antiasthmatic therapy · Adults aged 25–50 with persistent mild to moderate bronchial asthma | 250 mg | 16 weeks | — |
| Effect of high dose vitamin C supplementation on muscle soreness, damage, function, and oxidative stress to eccentric exercise 2006 · vitamin C (VC) treatment group · healthy men | 3 g | 18 days | — |
| The effect of antioxidant vitamins E and C on cognitive performance of the elderly with mild cognitive impairment in Isfahan, Iran: a double-blind, randomized, placebo-controlled trial 2014 · antioxidant supplementation · Adults aged 60–75 years with mild cognitive impairment | 400 mg | 1 year | — |
| Randomized Clinical Trial of Antioxidant Therapy Patients with Septic Shock and Organ Dysfunction in the ICU: SOFA Score Reduction by Improvement of the Enzymatic and Non-Enzymatic Antioxidant System 2023 · Group 1 (Vit C) · Adults older than 18 years of any gender with septic shock admitted to the ICU | 4 g | 5 days | — |
| Impact of Treatment with Antioxidants as an Adjuvant to Standard Therapy in Patients with Septic Shock: Analysis of the Correlation between Cytokine Storm and Oxidative Stress and Therapeutic Effects 2023 · Group 1 (Vit C) · Adults over 18 years of any gender with septic shock | 4 g | 5 days | — |
| Effect of vitamins on the lipid profile of patients on regular hemodialysis 2000 · vitamin C · hemodialysis patients; age and sex not reported | 200 mg | 90 days | 21 |
| High doses of vitamin C plus E reduce strength training-induced improvements in areal bone mineral density in elderly men 2017 · antioxidant group (AO) · Healthy elderly men; age range not reported (mean age 70 ± 7 years) | 1 g | 12 weeks | 16 |
| The combination of vitamin C and grape-seed polyphenols increases blood pressure: a randomized, double-blind, placebo-controlled trial 2005 · vitamin C and grape-seed polyphenols · Treated hypertensive individuals with mean 24-hour ambulatory systolic blood pressure ≥125 mmHg | 500 mg | 6 weeks | — |
| Effects of Helicobacter pylori treatment and vitamin and garlic supplementation on gastric cancer incidence and mortality: follow-up of a randomized intervention trial 2019 · Vitamin supplementation · Rural Chinese adults aged 35–64 at high risk of gastric cancer, with and without H pylori infection | 500 mg | 2665 days | 1,677 |
| Impact of iron fortification on anaemia and iron deficiency among pre-school children living in Rural Ghana 2021 · iron-MNP group · Children aged 6–35 months living in rural Ghana; children with severe anaemia, severe malnutrition, recent iron supplementation, or chronic disease were excluded. | 30 mg | 150 days | 967 |
| Effects of fortified milk on morbidity in young children in north India: community based, randomised, double masked placebo controlled trial 2007 · fortified milk · Children aged 1–3 years in a peri-urban settlement in north India | 40.2 mg | 1 year | 316 |
| Regular vitamin C supplementation during pregnancy reduces hospitalization: outcomes of a Ugandan rural cohort study 2010 · Vitamin C group · Pregnant women aged at least 18, enrolled at 4–12 gestational weeks in Uganda | 400 mg | — | 187 |
| Antioxidant supplement and long-term reduction of recurrent adenomas of the large bowel. A double-blind randomized trial 2013 · active compound · Patients who had undergone polypectomy and were undergoing post-polypectomy endoscopic follow-up | 180 mg | 5 years | 164 |
| Megadose vitamins in bladder cancer: a double-blind clinical trial 1994 · megadose vitamins arm · Patients with biopsy-confirmed transitional cell carcinoma of the bladder receiving BCG immunotherapy | 2 g | — | 35 |
| "The SU.VI.MAX Study": a primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers. SUpplementation on VItamines et Minéraux AntioXydants 1999 · antioxidant vitamins and minerals supplementation · Women aged 35 to 60 years and men aged 45 to 60 years, without a stated condition | 120 mg | 8 years | — |
| A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8 2001 · Antioxidants plus zinc · Adults aged 55–80 with age-related macular degeneration Categories 2–4 and visual acuity of 20/32 or better in at least one eye | 500 mg | 8 years | — |
| Effects of multimicronutrient supplementation on helminth reinfection: a randomized, controlled trial in Kenyan schoolchildren 2003 · multimicronutrient supplementation · Schoolchildren in Nyanza Province, Kenya; age and sex not specified | 50 mg | 335 days | — |
| Effects of maternal micronutrient supplementation on fetal loss and infant mortality: a cluster-randomized trial in Nepal 2003 · Multiple micronutrients · Pregnant women in rural Nepal | 100 mg | — | — |
| Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13 2004 · antioxidants plus zinc · Adults aged 55–81 years with AMD categories 2–4 and AREDS ocular eligibility | 500 mg | 339 weeks | — |
| The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals 2004 · antioxidant supplement group · French women aged 35–60 and men aged 45–60 in the general population | 120 mg | 2739 days | — |
| Antioxidant status and risk of cancer in the SU.VI.MAX study: is the effect of supplementation dependent on baseline levels? 2005 · daily antioxidant supplementation · French adults: women aged 35–60 years and men aged 45–60 years | 120 mg | 2739 days | — |
| [The SU.VI.MAX study, a randomized, placebo-controlled trial on the effects of antioxidant vitamins and minerals on health] 2006 · antioxidant supplementation · Middle-aged adults in the general population | 120 mg | 2738 days | — |
| Antioxidant supplementation increases the risk of skin cancers in women but not in men 2007 · antioxidant group · French adult women and men in a general-population primary-prevention trial | 120 mg | 2738 days | — |
| Incidence of cancers, ischemic cardiovascular diseases and mortality during 5-year follow-up after stopping antioxidant vitamins and minerals supplements: a postintervention follow-up in the SU.VI.MAX Study 2010 · antioxidant supplementation · French women aged 35–60 years and men aged 45–60 years | 120 mg | 2738 days | — |
| Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35 2013 · Antioxidants plus zinc · Adults aged 55–80 with age-related macular degeneration (AREDS categories 1–4) | 500 mg | 339 weeks | — |
| No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38 2014 · antioxidants plus zinc · Adults with intermediate age-related macular degeneration in one or both eyes or late age-related macular degeneration in one eye; mean age 69 years | 500 mg | 9 years | — |
| Supplementation with multivitamins and vitamin A and incidence of malaria among HIV-infected Tanzanian women 2014 · multivitamins without vitamin A · HIV-infected pregnant women in Tanzania | 500 mg | 1249 days | — |
| Supplementation with multivitamins and vitamin A and incidence of malaria among HIV-infected Tanzanian women 2014 · multivitamins with vitamin A · HIV-infected pregnant women in Tanzania | 500 mg | 1249 days | — |
| Effect of micronutrient supplementation on infection in institutionalized elderly subjects: a controlled trial 1997 · combination of trace elements and vitamins · Institutionalized elderly subjects in a geriatric center; low serum vitamin C, zinc and selenium were common at baseline | 120 mg | 2 years | — |
| Growth and recurrence of colorectal polyps: a double-blind 3-year intervention with calcium and antioxidants 1998 · active medication · Adults with colorectal polyps; age range and sex not stated | 150 mg | 3 years | — |
| Combination of Chemically Characterized Pomegranate Extract and Hydrophilic Vitamins against Prolonged Fatigue: A Monocentric, Randomized, Double-Blind, Placebo-Controlled Clinical Trial 2023 · Group 2 (food supplement) · Adults aged 18–75 years, either sex, with mild-to-moderate prolonged fatigue | 200 mg | 8 weeks | 29 |
| Effects of vitamin C, vitamin E, zinc gluconate, and selenomethionine supplementation on muscle function and oxidative stress biomarkers in patients with facioscapulohumeral dystrophy: a double-blind randomized controlled clinical trial 2015 · supplemented group · Adults with facioscapulohumeral muscular dystrophy (FSHD) | 500 mg | 17 weeks | 26 |
| Improving neuropathy scores in type 2 diabetic patients using micronutrients supplementation 2011 · Group MV · Patients with type 2 diabetes | 200 mg | 120 days | — |
| Beneficial effects of pleuran on asthma control and respiratory tract-infection frequency in children with perennial asthma 2025 · Active (Imunoglukan P4H®) group · Children aged 7–17 years, both sexes, with partially controlled perennial asthma and at least two respiratory infection-induced acute asthma exacerbations in the prior 12 months | 200 mg | 24 weeks | 125 |
| Probiotics with vitamin C for the prevention of upper respiratory tract symptoms in children aged 3-10 years: randomised controlled trial 2021 · active group · Healthy school children aged 3–10 years | 50 mg | 26 weeks | 86 |
| Impact of L-arginine and liposomal vitamin C supplementation on quality of life and daily life activities in patients with COPD: a randomized, multicenter, single blind, placebo-controlled trial (ILDA study) 2025 · L-arginine group · Patients with stable COPD; age and sex not specified | 1 g | 4 weeks | 76 |
| Antioxidant supplementation reduces endometriosis-related pelvic pain in humans 2013 · Group A · Women aged 19–41 with pelvic pain and a history of endometriosis and/or infertility | 1 g | 8 weeks | 46 |
| Probiotics and vitamin C for the prevention of respiratory tract infections in children attending preschool: a randomised controlled pilot study 2015 · active group · Healthy preschool children aged 3–6 years in Slovakia | 50 mg | 26 weeks | 34 |
| A Novel Fortified Dairy Product and Sarcopenia Measures in Sarcopenic Older Adults: A Double-Blind Randomized Controlled Trial 2021 · intervention group · Community-recruited older adults with sarcopenia | 500 mg | 12 weeks | 33 |
| Effects of antioxidant vitamins C and E on signal-averaged electrocardiogram in acute myocardial infarction 1996 · supplemented group · Patients with acute myocardial infarction | 600 mg | 2 weeks | 33 |
| Does vitamin C or its combination with vitamin E improve radial artery endothelium-dependent vasodilatation in patients awaiting coronary artery bypass surgery? 2013 · vitamins C + E group (group 2) · Adults with angiographically confirmed significant coronary artery disease awaiting coronary artery bypass surgery | 2 g | 1 day | 31 |
| Acute autonomic effects of vitamins and fats in male smokers 2009 · moderate vitamins · Male smokers, mean age 34.2 years (SD 6.9) | 300 mg | 1 day | 30 |
| Acute autonomic effects of vitamins and fats in male smokers 2009 · high doses of vitamins · Male smokers, mean age 34.2 years (SD 6.9) | 2 g | 1 day | 30 |
| Novel 1 L polyethylene glycol-based bowel preparation (NER1006): proof of concept assessment versus standard 2 L polyethylene glycol with ascorbate - a randomized, parallel group, phase 2, colonoscopist-blinded trial 2019 · LVPEG-2 (Part 1) · Healthy male and female volunteers aged 40–70 years | 55.6 g | 2 days | 30 |
| Novel 1 L polyethylene glycol-based bowel preparation (NER1006): proof of concept assessment versus standard 2 L polyethylene glycol with ascorbate - a randomized, parallel group, phase 2, colonoscopist-blinded trial 2019 · LVPEG-3 (Part 1) · Healthy male and female volunteers aged 40–70 years | 55.6 g | 2 days | 30 |
| Novel 1 L polyethylene glycol-based bowel preparation (NER1006): proof of concept assessment versus standard 2 L polyethylene glycol with ascorbate - a randomized, parallel group, phase 2, colonoscopist-blinded trial 2019 · LVPEG-3 (Part 2) · Adults aged 40–70 years at known personal or familial colorectal cancer risk, or aged 55–70 years, undergoing screening colonoscopy | 55.6 g | 2 days | 30 |
| Novel 1 L polyethylene glycol-based bowel preparation (NER1006): proof of concept assessment versus standard 2 L polyethylene glycol with ascorbate - a randomized, parallel group, phase 2, colonoscopist-blinded trial 2019 · LVPEG-4 (Part 2) · Adults aged 40–70 years at known personal or familial colorectal cancer risk, or aged 55–70 years, undergoing screening colonoscopy | 55.6 g | 2 days | 30 |
| The Effects of Dietary Supplementation with Collagen and Vitamin C and Their Combination with Hyaluronic Acid on Skin Density, Texture and Other Parameters: A Randomised, Double-Blind, Placebo-Controlled Trial 2024 · CP group · Healthy Caucasian women aged 40–65 years with skin ageing | 80 mg | 16 weeks | 30 |
| The Effects of Dietary Supplementation with Collagen and Vitamin C and Their Combination with Hyaluronic Acid on Skin Density, Texture and Other Parameters: A Randomised, Double-Blind, Placebo-Controlled Trial 2024 · CPHA group · Healthy Caucasian women aged 40–65 years with skin ageing | 80 mg | 16 weeks | 30 |
| L-ascorbic acid addition to chitosan reduces body weight in overweight women 2014 · Chito-vita group · Overweight women | 2 g | 8 weeks | 27 |
| Randomized Trial of Vitamin C/E Complex for Prevention of Radiation-Induced Xerostomia in Patients with Head and Neck Cancer 2016 · trial group · Patients with head and neck cancer receiving radiotherapy; age and sex not reported | 1 g | — | 25 |
| Effects of l-Arginine Plus Vitamin C Supplementation on Physical Performance, Endothelial Function, and Persistent Fatigue in Adults with Long COVID: A Single-Blind Randomized Controlled Trial 2022 · l-arginine plus vitamin C · Men and women aged 20–60 with long COVID and persistent fatigue | 1 g | 4 weeks | 25 |
| Protective effect of anti-oxidants on endothelial function in young Korean-Asians compared to Caucasians 2012 · antioxidant vitamins · Healthy Korean and Caucasian adults aged 20–35 years | 1 g | 2 weeks | 20 |
| Effect of antioxidant vitamins on the transient impairment of endothelium-dependent brachial artery vasoactivity following a single high-fat meal 1997 · high-fat meal with vitamins · Healthy, normocholesterolemic men and women aged 24 to 54 years | 1 g | 1 day | 20 |
| Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia: an effect reversible with vitamin C therapy 1999 · oral methionine preceded by vitamin C · Healthy adults aged 21–59 years; 10 male and 7 female; no stated condition | 1 g | 7 days | 17 |
| Impairment of coronary circulation by acute hyperhomocysteinaemia and reversal by antioxidant vitamins 2004 · methionine load with antioxidant vitamins · Healthy volunteers aged 26–40 years; nine men and seven women, with no stated condition | 1 g | 1 day | 16 |
| Effect of strength training combined with antioxidant supplementation on muscular performance 2018 · vitamins · Women, mean age 23.8 years, participating in strength training; no diagnosed condition stated | 1 g | 10 weeks | 15 |
| Improved lung function following dietary antioxidant supplementation in exercise-induced asthmatics 2016 · Vitamins (V) · Adults with exercise-induced asthma (mean age 22.0 years) and healthy controls (mean age 28.2 years) | 500 mg | 3 weeks | 13 |
| Acute effects of ozone on pulmonary function of cyclists receiving antioxidant supplements 1998 · supplementation group · Amateur cyclists; age and sex not reported; no condition stated | 650 mg | 90 days | 12 |
| Effect of antioxidant vitamins on the transient impairment of endothelium-dependent brachial artery vasoactivity following a single high-fat meal 1997 · low-fat meal with vitamins · A subgroup of healthy, normocholesterolemic men and women aged 24 to 54 years | 1 g | 1 day | 10 |
| Effect of vitamin supplementation on lung injury and running performance in a hot, humid, and ozone-polluted environment 2011 · Vitamin trial · Runners; age, sex, and health condition not specified | 500 mg | 2 weeks | 9 |
| Acute methionine loading does not alter arterial stiffness in humans 2001 · methionine plus vitamin C · healthy men, mean age 29 years (range 20–42) | 2 g | 1 day | 8 |
| The effects of acute oral antioxidants on diving-induced alterations in human cardiovascular function 2007 · acute antioxidants · Experienced divers; age and sex not reported | 2 g | 1 day | 6 |
| Effects of micronutrient antioxidants (alpha-tocopherol and ascorbic acid) on skin thickening and lung function in patients with early diffuse systemic sclerosis 2011 · Subgroup A · Patients with early diffuse systemic sclerosis, positive anti-topoisomerase-I antibody, high skin thickening progression rate and decreased lung diffusing capacity; age and sex not reported | 1 g | 26 weeks | 6 |
| The Roche European American Cataract Trial (REACT): a randomized clinical trial to investigate the efficacy of an oral antioxidant micronutrient mixture to slow progression of age-related cataract 2002 · vitamin group · Adult American and English outpatients with early age-related cataract | 750 mg | 3 years | — |
| UVB photoprotection with antioxidants: effects of oral therapy with d-alpha-tocopherol and ascorbic acid on the minimal erythema dose 2002 · Group 3 · Healthy volunteers | 2 g | 7 days | — |
| Antioxidant supplementation and lung functions among children with asthma exposed to high levels of air pollutants 2002 · vitamin supplement group · Children with asthma living in Mexico City; age and asthma severity not specified | 250 mg | — | — |
| Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study 2003 · supplemented group · Men and postmenopausal women aged 45–69 years, smoking or nonsmoking, with serum cholesterol ≥5.0 mmol/L | 500 mg | 6 years | — |
| Oral antioxidant therapy improves endothelial function in Type 1 but not Type 2 diabetes mellitus 2003 · oral antioxidant therapy · People with Type 1 or Type 2 diabetes and matched healthy control subjects; ages and sex not reported | 1 g | 26 weeks | — |
| Antioxidant vitamins C and E improve endothelial function in children with hyperlipidemia: Endothelial Assessment of Risk from Lipids in Youth (EARLY) Trial 2003 · antioxidant vitamin therapy · children with familial hypercholesterolemia or the phenotype of familial combined hyperlipidemia | 500 mg | 6 weeks | — |
| Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis 2003 · vitamins E and C · Patients with nonalcoholic steatohepatitis (NASH); age and sex not specified | 1 g | 26 weeks | — |
| Effects of dietary supplementation with vitamins C and E on muscle function during and after eccentric contractions in humans 2004 · treatment group · male volunteers; no age range or diagnosed condition reported | 500 mg | 37 days | — |
| Maternal iron deficiency anemia affects postpartum emotions and cognition 2005 · daily iron · Young postpartum mothers with iron-deficiency anemia; age range not stated | 25 mg | 26 weeks | — |
| Comparative effects of enzogenol and vitamin C supplementation versus vitamin C alone on endothelial function and biochemical markers of oxidative stress and inflammation in chronic smokers 2006 · Enzogenol and vitamin C · Chronic smokers without established cardiovascular disease | 60 mg | 12 weeks | — |
| Effects of collagen tripeptide supplement on skin properties: a prospective, randomized, controlled study 2014 · Group C · Healthy volunteers; age and sex not specified | 500 mg | 12 weeks | — |
| Antioxidants improve vascular function in children conceived by assisted reproductive technologies: A randomized double-blind placebo-controlled trial 2015 · Antioxidant vitamins · Children conceived by assisted reproductive technology (ART) | 1 g | 4 weeks | — |
| Antioxidants improve vascular function in children conceived by assisted reproductive technologies: A randomized double-blind placebo-controlled trial 2015 · Antioxidant vitamins · Control children (children not conceived by assisted reproductive technology) | 1 g | 4 weeks | — |
| Amelioration of persistent left ventricular function impairment through increased plasma ascorbate levels following myocardial infarction 2016 · HA group (high ascorbate, >1 mmol/l) · Patients of either sex with a first ST-segment elevation myocardial infarction undergoing primary percutaneous coronary angioplasty | 1 g | 12 weeks | — |
| Amelioration of persistent left ventricular function impairment through increased plasma ascorbate levels following myocardial infarction 2016 · LA group (low ascorbate, <1 mmol/l) · Patients of either sex with a first ST-segment elevation myocardial infarction undergoing primary percutaneous coronary angioplasty | 1 g | 12 weeks | — |
| Mechanical Ventilation Antioxidant Trial 2015 · vitamin C plus vitamin E · critically ill adults requiring mechanical ventilation | 3 g | — | — |
| Mechanical Ventilation Antioxidant Trial 2015 · vitamin C plus vitamin E plus N-acetylcysteine · critically ill adults requiring mechanical ventilation | 3 g | — | — |
| Collagen and Vitamin C Supplementation Increases Lower Limb Rate of Force Development 2022 · HC + C · Healthy male athletes aged 18–25 years | 50 mg | 3 weeks | — |
| Protective effect against sunburn of combined systemic ascorbic acid (vitamin C) and d-alpha-tocopherol (vitamin E) 1998 · vitamins C and E · Human subjects; age, sex, and health status not specified; assessed for sunburn response | 2 g | 8 days | — |
| Antioxidant supplementation and respiratory functions among workers exposed to high levels of ozone 1998 · supplement group · Mexico City street workers exposed to high ozone levels; age and sex not stated | 650 mg | 26 weeks | — |
| Modulation of UV-light-induced skin inflammation by D-alpha-tocopherol and L-ascorbic acid: a clinical study using solar simulated radiation 1998 · Group (3) · Healthy volunteers | 3 g | 50 days | — |
| The impact of vitamins and/or mineral supplementation on blood pressure in type 2 diabetes 2004 · group V · People with type 2 diabetes; age and sex not reported | 200 mg | 90 days | 18 |
| Effects of inorganic nitrate and vitamin C co-supplementation on blood pressure and vascular function in younger and older healthy adults: A randomised double-blind crossover trial 2020 · Vitamin C · Healthy adults aged 18–40 years and 55–70 years | 20 mg/kg | 1 day | — |
| Effects of vitamin C on the outcome of in vitro fertilization-embryo transfer in endometriosis: A randomized controlled study 2018 · EMs treatment group · Women under 40 with endometriosis-related infertility undergoing IVF-ET | 1 g | 60 days | 137 |
| Effect of five-year supplementation of vitamin C on serum vitamin C concentration and consumption of vegetables and fruits in middle-aged Japanese: a randomized controlled trial 2003 · 500 mg/day vitamin C group · Middle-aged Japanese adults with atrophic gastritis | 500 mg | 1826 days | 124 |
| Comparative Effectiveness of Ascorbic Acid vs. Calcium Ascorbate Ingestion on Pharmacokinetic Profiles and Immune Biomarkers in Healthy Adults: A Preliminary Study 2024 · 500 mg ascorbic acid (high-dose study) · Healthy adults aged 18–60 years, male and female | 500 mg | 1 day | 47 |
| Comparative Effectiveness of Ascorbic Acid vs. Calcium Ascorbate Ingestion on Pharmacokinetic Profiles and Immune Biomarkers in Healthy Adults: A Preliminary Study 2024 · 500 mg calcium ascorbate (high-dose study) · Healthy adults aged 18–60 years, male and female | 500 mg | 1 day | 47 |
| Comparative Effectiveness of Ascorbic Acid vs. Calcium Ascorbate Ingestion on Pharmacokinetic Profiles and Immune Biomarkers in Healthy Adults: A Preliminary Study 2024 · 250 mg ascorbic acid (low-dose study) · Healthy adults aged 18–60 years, male and female | 250 mg | 1 day | 46 |
| Comparative Effectiveness of Ascorbic Acid vs. Calcium Ascorbate Ingestion on Pharmacokinetic Profiles and Immune Biomarkers in Healthy Adults: A Preliminary Study 2024 · 250 mg calcium ascorbate (low-dose study) · Healthy adults aged 18–60 years, male and female | 250 mg | 1 day | 46 |
| Inter-individual variability in redox and performance responses after antioxidant supplementation: A randomized double blind crossover study 2023 · vitamin C · People in the low plasma vitamin C group (age and sex not specified) | 1 g | 30 days | 22 |
| Effects of three-month oral supplementation of beta-carotene and vitamin C on serum concentrations of carotenoids and vitamins in middle-aged subjects: a pilot study for a randomized controlled trial to prevent gastric cancer in high-risk Japanese population 2000 · High-dose vitamin C group · Adults aged 40–69 with chronic atrophic gastritis | 1 g | 90 days | 20 |
| Oral vitamin C supplementation to patients with myeloid cancer on azacitidine treatment: Normalization of plasma vitamin C induces epigenetic changes 2019 · Vitamin C · Adults aged 57–84 with MDS, AML, or CMML receiving 5-azacytidine | 500 mg | 8 weeks | 10 |
| Ascorbic acid induces a favorable lipoprotein profile in women 1996 · ascorbic acid supplementation · healthy young women | 1 g | 4 weeks | 10 |
| High-dose vitamin C supplementation increases skeletal muscle vitamin C concentration and SVCT2 transporter expression but does not alter redox status in healthy males 2014 · Vitamin C supplementation · Healthy males; age not reported | 1 g | 6 weeks | 8 |
| Impact of tofu or tofu + orange juice on hematological indices of lacto-ovo vegetarian females 2002 · tofu plus orange juice (TO) · premenopausal lacto-ovo vegetarian women | 303 mg | 30 days | 7 |
| New evidence for antioxidant properties of vitamin C 2000 · 500 mg ascorbic acid · Healthy volunteers; age and sex not specified | 500 mg | 2 weeks | — |
| New evidence for antioxidant properties of vitamin C 2000 · 1,000 mg ascorbic acid · Healthy volunteers; age and sex not specified | 1 g | 2 weeks | — |
| Effect of vitamin C and zinc on osmotic fragility and lipid peroxidation in zinc-deficient haemodialysis patients 2002 · vitamin C · Zinc-deficient haemodialysis patients | 250 mg | 90 days | — |
| Effect of folic acid and vitamin C supplementation on folate status and homocysteine level: a randomised controlled trial in Italian smoker-blood donors 2002 · B: vitamin C · Italian repeat blood donors who smoked more than 15 cigarettes per day; age and sex not specified | 500 mg | 45 days | — |
| Comparison of the effects of simultaneous administration of vitamin C and omega-3 fatty acids on lipoproteins, apo A-I, apo B, and malondialdehyde in hyperlipidemic patients 2003 · VitC group · Hyperlipidemic patients with total cholesterol and triglycerides greater than 200 mg/dL; age and sex not specified | 500 mg | 10 weeks | — |
| Vitamin C supplementation influences the antioxidant response and nitric oxide handling of erythrocytes and lymphocytes to diving apnea 2006 · vitamin C supplemented group · Seven male professional apnea divers | 1 g | 7 days | — |
| Augmentation of respiratory tract lining fluid ascorbate concentrations through supplementation with vitamin C 2009 · 250 mg/day ascorbate group · Healthy subjects with low plasma ascorbate (<50 μM) | 250 mg | 2 weeks | — |
| Augmentation of respiratory tract lining fluid ascorbate concentrations through supplementation with vitamin C 2009 · 500 mg/day ascorbate group · Healthy subjects with low plasma ascorbate (<50 μM) | 500 mg | 2 weeks | — |
| Augmentation of respiratory tract lining fluid ascorbate concentrations through supplementation with vitamin C 2009 · 1000 mg/day ascorbate group · Healthy subjects with low plasma ascorbate (<50 μM) | 1 g | 2 weeks | — |
| Improvement in iron deficiency anemia through therapy with ferric ammonium citrate and vitamin C and the effects of aerobic exercise 1991 · Group I · Female college-student volunteers with iron-deficiency anemia or severe latent iron deficiency | 500 mg | 9 weeks | — |
| Improvement in iron deficiency anemia through therapy with ferric ammonium citrate and vitamin C and the effects of aerobic exercise 1991 · Group III · Female college-student volunteers with iron-deficiency anemia or severe latent iron deficiency | 500 mg | 9 weeks | — |
| Plasma vitamin C and tocotrienols changes in response to dietary supplementation among young male adults 2010 · Vitamin C · young male police recruits | 500 mg | 8 weeks | — |
| Vitamin C Bioequivalence from Gummy and Caplet Sources in Healthy Adults: A Randomized-Controlled Trial 2020 · gummy · Healthy men and women, mean age 34.0 ± 11.4 years | 1 g | 1 day | — |
| Vitamin C Bioequivalence from Gummy and Caplet Sources in Healthy Adults: A Randomized-Controlled Trial 2020 · caplet · Healthy men and women, mean age 34.0 ± 11.4 years | 1 g | 1 day | — |
| Micronutrient fortified milk improves iron status, anemia and growth among children 1-4 years: a double masked, randomized, controlled trial 2010 · Micronutrient-fortified milk (MN group) · Children aged 1–4 years in India; many had anemia, iron deficiency, or growth faltering | 40.2 mg | 1 year | 316 |
| Acute reversal of endothelial dysfunction in the elderly after antioxidant consumption 2012 · Antioxidant cocktail · Healthy young adults (mean age 25 ± 1 years) and older adults (mean age 71 ± 1 years), free of overt cardiovascular disease | 1 g | 1 day | 87 |
| Evaluation of the efficacy of 1 L polyethylene glycol plus ascorbic acid and an oral sodium sulfate solution: A multi-center, prospective randomized controlled trial 2022 · 1 L PEG/Asc (CleanViewAL) · Outpatients aged 20–65 undergoing colonoscopy for diagnosis, screening, surveillance, or treatment | 50 g | 1 day | 85 |
| Melatonin, vitamins and minerals supplements for the treatment of Covid-19 and Covid-like illness: A prospective, randomized, double-blind multicenter study 2024 · Treatment group · Adults younger than 60 years with COVID-19 or COVID-like illness, no previous medical history, and not hospitalized | 40 mg | — | 82 |
| Vascular dysfunction and chronic obstructive pulmonary disease: the role of redox balance 2014 · Antioxidant cocktail (AOC) · Adults: 30 patients with COPD and 30 age- and sex-matched controls | 1 g | 1 day | 60 |
| Wrinkle reduction in post-menopausal women consuming a novel oral supplement: a double-blind placebo-controlled randomized study 2014 · Test group 1 · Healthy, non-smoking post-menopausal women, skin types I–III, not receiving HRT and with BMI 18–33 kg/m² | 250 mg | 14 weeks | 55 |
| Wrinkle reduction in post-menopausal women consuming a novel oral supplement: a double-blind placebo-controlled randomized study 2014 · Test group 2 · Healthy, non-smoking post-menopausal women, skin types I–III, not receiving HRT and with BMI 18–33 kg/m² | 180 mg | 14 weeks | 55 |
| Efficacy and safety of 1 L polyethylene glycol plus ascorbic acid for bowel preparation in elderly: comparison with oral sulfate solution 2023 · 1 L PEG/Asc · Adults aged 65–84 undergoing screening or surveillance colonoscopy; older adults, with or without comorbidities | 100 g | 1 day | 52 |
| A Collagen Supplement Improves Skin Hydration, Elasticity, Roughness, and Density: Results of a Randomized, Placebo-Controlled, Blind Study 2019 · verum group · Women aged 35–73 with healthy skin | 80 mg | 12 weeks | 36 |
| [Study of the antioxidant drug "Karinat" in patients with chronic atrophic gastritis] 2004 · Karinat · Patients with chronic multifocal atrophic gastritis | 60 mg | 26 weeks | 34 |
| [Study of an antioxidant dietary supplement "Karinat" in patients with benign breast disease] 2004 · Karinat · Patients with benign breast disease, including mastopathy | 60 mg | 26 weeks | 33 |
| Increased vitamin plasma levels in Swedish military personnel treated with nutrients prior to automatic weapon training 2011 · Nutrients (active treatment) · Normally hearing Swedish military personnel, officers and military academy trainees, ages 18 and older, undergoing weapons training | 500 mg | 2 days | 31 |
| Dietary Intervention With a Targeted Micronutrient Formulation Reduces the Visual Discomfort Associated With Vitreous Degeneration 2021 · active group · Adults aged 18 years and older with primary age-related or myopia-related vitreous floaters | 40 mg | 26 weeks | 31 |
| A Dermonutrient Containing Special Collagen Peptides Improves Skin Structure and Function: A Randomized, Placebo-Controlled, Triple-Blind Trial Using Confocal Laser Scanning Microscopy on the Cosmetic Effects and Tolerance of a Drinkable Collagen Supplement 2020 · test product (Elasten) · Women aged 40–70 years; healthy, without a stated skin disease | 80 mg | 12 weeks | 30 |
| Effects of ingesting a pre-workout dietary supplement with and without synephrine for 8 weeks on training adaptations in resistance-trained males 2017 · PWS · Apparently healthy, resistance-trained males; mean age about 21 years | 500 mg | 8 weeks | 27 |
| Effects of ingesting a pre-workout dietary supplement with and without synephrine for 8 weeks on training adaptations in resistance-trained males 2017 · PWS + S · Apparently healthy, resistance-trained males; mean age about 22 years | 500 mg | 8 weeks | 26 |
| A Dietary Supplement in the Management of Patients with Lumbar Osteochondrosis: A Randomized, Double-Blinded, Placebo-Controlled Study 2024 · supplement group · Adults with symptomatic MRI-confirmed lumbar osteochondrosis; age range and sex not specified | 60 mg | 90 days | 26 |
| Effects of acute ingestion of a pre-workout dietary supplement with and without p-synephrine on resting energy expenditure, cognitive function and exercise performance 2017 · PWS · Resistance-trained healthy adults; 20 men and 5 women, mean age 21.7 years | 500 mg | 1 day | 25 |
| Effects of acute ingestion of a pre-workout dietary supplement with and without p-synephrine on resting energy expenditure, cognitive function and exercise performance 2017 · PWS + S · Resistance-trained healthy adults; 20 men and 5 women, mean age 21.7 years | 500 mg | 1 day | 25 |
| The Effect of a Multivitamin and Mineral Supplement on Immune Function in Healthy Older Adults: A Double-Blind, Randomized, Controlled Trial 2020 · Redoxon® Vita Immune (MVM) · Healthy men and women aged 55–75 years | 1 g | 12 weeks | 21 |
| Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins 1999 · Methionine load with antioxidant vitamins · Healthy adults aged 25 to 45 years; 10 men and 10 women | 1 g | 1 day | 20 |
| Nutraceutical Supplementation as a Potential Non-Drug Treatment for Fibromyalgia: Effects on Lipid Profile, Oxidative Status, and Quality of Life 2024 · Group 1 (Mygrium®) · Adult women over 18 years with previously diagnosed fibromyalgia | 120 mg | 60 days | 20 |
| Carotenoids and antioxidants in age-related maculopathy italian study: multifocal electroretinogram modifications after 1 year 2008 · treated AMD (T-AMD) group · Patients with nonadvanced age-related macular degeneration; mean age 69.4 years | 180 mg | 1 year | 15 |
| Effects of Macuprev(®) Supplementation in Age-Related Macular Degeneration: A Double-Blind Randomized Morpho-Functional Study Along 6 Months of Follow-Up 2019 · AMD-M group · Adults with intermediate age-related macular degeneration; 9 male and 21 female enrolled overall, mean age 69.32 years | 160 mg | 26 weeks | 15 |
| Glucosamine, chondroitin, and manganese ascorbate for degenerative joint disease of the knee or low back: a randomized, double-blind, placebo-controlled pilot study 1999 · combination therapy · male U.S. Navy diving and special warfare personnel with chronic pain and radiographic degenerative joint disease of the knee or low back | 228 mg | 16 weeks | — |
| Treatment with supplementary arginine, vitamin C and zinc in patients with pressure ulcers: a randomised controlled trial 2005 · Standard diet plus two high-protein/energy supplements containing additional arginine, vitamin C and zinc · Inpatients aged 37–92 years with stage 2, 3 or 4 pressure ulcers | 500 mg | 3 weeks | — |
| Changes in ventilatory threshold at high altitude: effect of antioxidants 2006 · antioxidant (AO) supplement group · Physically fit males aged 25 ± 5 years exposed to high altitude at 4300 m | 500 mg | 5 weeks | — |
| Improving neuropathy scores in type 2 diabetic patients using micronutrients supplementation 2011 · Group MVB · Patients with type 2 diabetes | 200 mg | 120 days | — |
| French adults' cognitive performance after daily supplementation with antioxidant vitamins and minerals at nutritional doses: a post hoc analysis of the Supplementation in Vitamins and Mineral Antioxidants (SU.VI.MAX) trial 2011 · antioxidant supplementation · French adults aged 45–60 years enrolled in the SU.VI.MAX study | 120 mg | 2922 days | — |
| Low-dose B vitamins supplementation ameliorates cardiovascular risk: a double-blind randomized controlled trial in healthy Chinese elderly 2015 · treatment group · Healthy adults aged 60–74 years | 50 mg | 1 year | — |
| Supplemental Protein and a Multinutrient Beverage Speed Wound Healing after Acute Sleep Restriction in Healthy Adults 2022 · NUT · Generally healthy young adults aged 18–approximately 20 years (18 males and 2 females), after acute sleep restriction | 400 mg | 7 days | — |
| The impact of vitamins and/or mineral supplementation on blood pressure in type 2 diabetes 2004 · group MV · People with type 2 diabetes; age and sex not reported | 200 mg | 90 days | 17 |
| Combined effect of metformin with ascorbic acid versus acetyl salicylic acid on diabetes-related cardiovascular complication; a 12-month single blind multicenter randomized control trial 2017 · Parallel arm I (metformin + Ascorbic Acid (ACA) 500 mg) · Adults aged 18 years or older with newly diagnosed type 2 diabetes (within 5 years), elevated glucose measures, taking metformin only | 500 mg | 1 year | 152 |
| Improvements in lung function following vitamin C supplementation to pregnant smokers are associated with buccal DNA methylation at 5 years of age 2024 · Vitamin C · Pregnant women aged at least 15 years with singleton pregnancies under 23 weeks, who currently smoked and were unable or unwilling to quit; offspring assessed at 5 years | 500 mg | — | 125 |
| The effect of 5-year vitamin C supplementation on serum pepsinogen level and Helicobacter pylori infection 2003 · high-dose group · Adults aged 40–69 with chronic gastritis in a high-risk area for gastric cancer in Japan | 500 mg | 5 years | 124 |
| Plasma lipids, lipoproteins and atherogenic index in men and women administered vitamin C 1992 · experimental group · Men and women with hyperlipidaemia | 500 mg | 548 days | 83 |
| Vitamin C supplementation to pregnant smokers alters asthma- and allergy-associated CpGs in child buccal DNA at 5 years of age 2025 · vitamin C · Pregnant smokers; offspring were assessed at 5 years of age | 500 mg | — | 72 |
| Effects of oral vitamin C on monocyte: endothelial cell adhesion in healthy subjects 2002 · vitamin C supplementation · Healthy non-smokers with normal or below-average plasma vitamin C concentrations | 250 mg | 6 weeks | 40 |
| Metabolic benefits deriving from chronic vitamin C supplementation in aged non-insulin dependent diabetics 1995 · vitamin C · Adults aged about 72 years with type II diabetes, treated with oral hypoglycaemic agents | 1 g | 120 days | 40 |
| Impact of vitamin E and C supplementation on serum adhesion molecules in chronic degenerative aortic stenosis: a randomized controlled trial 2005 · vitamin C only group · Patients with asymptomatic or mildly symptomatic moderate chronic degenerative aortic stenosis, with or without concomitant coronary artery disease; age and sex not reported | 1 g | 26 weeks | 39 |
| Effect of vitamin C on inflammation and metabolic markers in hypertensive and/or diabetic obese adults: a randomized controlled trial 2015 · vitamin C treatment group · Adults aged 20–60 with obesity and hypertension and/or type 2 diabetes, and high hs-CRP | 1 g | 8 weeks | 36 |
| Effects of selenium and vitamin C on the serum level of antithyroid peroxidase antibody in patients with autoimmune thyroiditis 2019 · Group two (GII) · People aged 15–78 years with autoimmune thyroiditis; sex not specified | 500 mg | 90 days | 36 |
| Effect of Vitamin C on adrenal suppression by etomidate induction in patients undergoing cardiac surgery: A randomized controlled trial 2016 · Group-I · Adults aged 25–60, either sex, undergoing elective cardiac surgery, without endocrine disease | 1 g | 7 days | 35 |
| Does vitamin C supplementation influence the levels of circulating oxidized LDL, sICAM-1, sVCAM-1 and vWF-antigen in healthy male smokers? 2004 · vitamin C · Healthy male smokers aged 26–73 years | 500 mg | 4 weeks | 34 |
| Ascorbic acid supplementation improves postprandial glycaemic control and blood pressure in individuals with type 2 diabetes: Findings of a randomized cross-over trial 2019 · ascorbic acid supplementation · Adults with type 2 diabetes; 26 males and 5 females, mean age 61.8 years | 1 g | 120 days | 31 |
| Interactions between vitamins C and E in human subjects 2000 · Vitamin C supplementation · healthy adults; sex and age range not stated | 500 mg | 6 weeks | 30 |
| Corticosteroid sparing effects of vitamin C and magnesium in asthma: a randomised trial 2006 · vitamin C · Adults with asthma | 1 g | 10 weeks | 29 |
| Ascorbic Acid may Exacerbate Aspirin-Induced Increase in Intestinal Permeability 2015 · 500 mg ascorbic acid alone · Healthy female volunteers; age not reported | 500 mg | 1 day | 28 |
| Ascorbic Acid may Exacerbate Aspirin-Induced Increase in Intestinal Permeability 2015 · Simultaneous ascorbic acid and aspirin · Healthy female volunteers; age not reported | 500 mg | 1 day | 28 |
| The effect of ascorbic acid supplementation on the blood lead levels of smokers 1999 · 1000 mg ascorbic acid group · Men aged 20–30 who smoked at least one pack of cigarettes per day and had no clinical signs of ascorbic acid deficiency or lead toxicity | 1 g | 4 weeks | 25 |
| Vitamin C supplementation improves blood pressure and oxidative stress after acute exercise in patients with poorly controlled type 2 diabetes mellitus: A randomized, placebo-controlled, cross-over study 2021 · Vitamin C arm · Adults with poorly controlled type 2 diabetes mellitus; mean age 53 ± 7 years | 1 g | 6 weeks | 24 |
| Gut microbiota links vitamin C supplementation to enhanced mental vitality in healthy young adults with suboptimal vitamin C status: A randomized, double-blind, placebo-controlled trial 2025 · vitamin C · Healthy adults aged 20–39 years with inadequate serum vitamin C levels (<50 μM) | 1 g | 4 weeks | 21 |
| Effects of nitrogen dioxide exposure and ascorbic acid supplementation on exhaled nitric oxide in healthy human subjects 2001 · ascorbic acid · healthy human subjects | 1 g | 2 weeks | 20 |
| Ascorbic Acid may Exacerbate Aspirin-Induced Increase in Intestinal Permeability 2015 · Ascorbic acid administered half an hour before aspirin · Healthy female volunteers; age not reported | 500 mg | 1 day | 19 |
| Ascorbic Acid may Exacerbate Aspirin-Induced Increase in Intestinal Permeability 2015 · Ascorbic acid administered half an hour after aspirin · Healthy female volunteers; age not reported | 500 mg | 1 day | 19 |
| Increased antioxidant capacity in healthy volunteers taking a mixture of oral antioxidants versus vitamin C or E supplementation 2007 · vitamin C · Healthy adults aged 19–23 years | 500 mg | 7 days | 18 |
| Citrus fruit supplementation reduces lipoprotein oxidation in young men ingesting a diet high in saturated fat: presumptive evidence for an interaction between vitamins C and E in vivo 1998 · high-C diet · healthy male students | 500 mg | 60 days | 18 |
| Acute and chronic effects of vitamin C on endothelial fibrinolytic function in overweight and obese adult humans 2008 · Chronic oral vitamin C supplementation · Overweight or obese adults; 17 completed the supplementation intervention | 500 mg | 90 days | 17 |
| Oxidative stress in humans during work at moderate altitude 1999 · vitamin C group · U.S. Marines engaged in moderate-altitude cold-weather field training; age and sex not reported | 500 mg | 4 weeks | 15 |
| Vitamin C intervention may lower the levels of persistent organic pollutants in blood of healthy women - A pilot study 2016 · Vitamin C supplementation · Healthy women; ages and sex-specific condition not further stated; included 8 women with obesity/overweight and 7 with normal weight | 1 g | 60 days | 15 |
| The Administration of Resveratrol and Vitamin C Reduces Oxidative Stress in Postmenopausal Women-A Pilot Randomized Clinical Trial 2024 · Group C (vitamin C and resveratrol placebo) · Women aged 50–60 with early postmenopause and insulin resistance | 500 mg | 90 days | 14 |
| Molecular detection of exercise-induced free radicals following ascorbate prophylaxis in type 1 diabetes mellitus: a randomised controlled trial 2008 · ascorbate group · Male patients with type 1 diabetes and healthy male controls | 1 g | 1 day | 13 |
| Vitamin C supplementation affects oxidative-stress blood markers in response to a 30-minute run at 75% VO2max 2005 · 500 mg/d vitamin C · Healthy males, mean age 25 years | 500 mg | 2 weeks | 12 |
| Vitamin C supplementation affects oxidative-stress blood markers in response to a 30-minute run at 75% VO2max 2005 · 1000 mg/d vitamin C · Healthy males, mean age 25 years | 1 g | 2 weeks | 12 |
| Antioxidant supplementation, redox deficiencies and exercise performance: A falsification design 2020 · Low VitC group — vitamin C treatment · 12 volunteers selected for having the lowest plasma vitamin C levels | 1 g | 30 days | 12 |
| Antioxidant supplementation, redox deficiencies and exercise performance: A falsification design 2020 · Low GSH group — vitamin C treatment · 12 volunteers selected for having the lowest erythrocyte glutathione levels | 1 g | 30 days | 12 |
| Antioxidant supplementation, redox deficiencies and exercise performance: A falsification design 2020 · Control group — vitamin C treatment · 12 volunteers with moderate vitamin C and glutathione levels | 1 g | 30 days | 12 |
| Effects of colon-targeted vitamins on the composition and metabolic activity of the human gut microbiome- a pilot study 2021 · Vitamin C · Healthy adult volunteers; age and sex range not specified | 500 mg | 4 weeks | 12 |
| The effect of pharmacological supplementation with vitamin C on low-density lipoprotein oxidation 1997 · vitamin C supplemented group · Healthy non-smoking adults; ages and sex not reported | 1 g | 4 weeks | 11 |
| Supplementation with vitamins C and E enhances cytokine production by peripheral blood mononuclear cells in healthy adults 1996 · vitamin C group · healthy adults; age range and sex not reported | 1 g | 4 weeks | 10 |
| Vitamin E and vitamin C supplementation in patients with chronic obstructive pulmonary disease 2007 · 250 mg/day vitamin C (C250) · Patients with stable COPD | 250 mg | 12 weeks | 9 |
| [Reduction of erythrocyte sorbitol by ascorbic acid in patients with diabetes mellitus] 1994 · ascorbic acid tablets · patients with diabetes mellitus; age and sex not reported | 1 g | 2 weeks | 8 |
| Total radical-trapping antioxidant potential (TRAP) of plasma: effects of supplementation of young healthy volunteers with large doses of alpha-tocopherol and ascorbic acid 1993 · Group 2, ascorbic acid · Young healthy adults; age range and sex not reported | 1 g | 4 weeks | 8 |
| Anti-Inflammatory, Antithrombotic and Antioxidant Efficacy and Synergy of a High-Dose Vitamin C Supplement Enriched with a Low Dose of Bioflavonoids; In Vitro Assessment and In Vivo Evaluation Through a Clinical Study in Healthy Subjects 2025 · VC · Healthy volunteers; age and sex range not specified | 1 g | 4 weeks | 7 |
| Effect of Chyawanprash and vitamin C on glucose tolerance and lipoprotein profile 2001 · Vitamin C group · Healthy adult men aged 20–32 years | 500 mg | 8 weeks | 5 |
| Effect of supplementation with tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes 2000 · vitamin C · Patients aged under 75 years with well-controlled type 2 diabetes | 500 mg | 4 weeks | — |
| The effect of vitamin E and vitamin C supplementation on LDL oxidizability and neutrophil respiratory burst in young smokers 2000 · vitamin C · young smokers with a history of less than 5 pack-years | 1 g | 8 weeks | — |
| The effects of vitamin C supplementation on protein oxidation in healthy volunteers 2000 · vitamin C · Healthy human volunteers, including participants with low or normal baseline ascorbate; age and sex not stated | 400 mg | 15 weeks | — |
| Long-term effects of vitamin E, vitamin C, and combined supplementation on urinary 7-hydro-8-oxo-2'-deoxyguanosine, serum cholesterol oxidation products, and oxidation resistance of lipids in nondepleted men 2000 · vitamin C · men described as nondepleted; age and condition not stated | 500 mg | 3 years | — |
| Potential problems of ascorbate and iron supplementation: pro-oxidant effect in vivo? 2000 · 260 mg/d ascorbate · 20 healthy subjects | 260 mg | 6 weeks | — |
| Supplementation with vitamin E but not with vitamin C lowers lipid peroxidation in vivo in mildly hypercholesterolemic men 2001 · vitamin C group · Clinically healthy men with mild hypercholesterolemia and normal vitamin C and E levels | 500 mg | 1 year | — |
| Antioxidant supplementation decreases lipid peroxidation biomarker F(2)-isoprostanes in plasma of smokers 2002 · Vitamin C · Smokers, mean age 46 years (range 20–78); reported benefit in the subgroup with BMI above the median | 500 mg | 60 days | — |
| A randomized, double-blind, controlled trial of vitamin C in the management of hypertension and lipids 2002 · 500 mg vitamin C · Adults with mild hypertension; mean age 62 years; 52% men | 500 mg | 26 weeks | — |
| A randomized, double-blind, controlled trial of vitamin C in the management of hypertension and lipids 2002 · 1000 mg vitamin C · Adults with mild hypertension; mean age 62 years; 52% men | 1 g | 26 weeks | — |
| Effects of vitamin C and vitamin E on in vivo lipid peroxidation: results of a randomized controlled trial 2002 · vitamin C alone · nonsmokers | 500 mg | 60 days | — |
| Protective effects of vitamin C on endothelium damage and platelet activation during myocardial infarction in patients with sustained generation of circulating microparticles 2003 · vitamin C-treated patients · Patients with myocardial infarction | 1 g | 5 days | — |
| Vitamin C supplementation in normal subjects reduces constitutive ICAM-1 expression 2003 · Vitamin C supplementation · Healthy male subjects with low plasma vitamin C at baseline (<50 microM) | 250 mg | 6 weeks | — |
| Effect of ascorbic acid supplementation on the sperm quality of smokers 1992 · 1,000 mg group · Men aged 20–35 who were heavy smokers | 1 g | 30 days | — |
| Plasma C-reactive protein concentrations in active and passive smokers: influence of antioxidant supplementation 2004 · vitamin C · Healthy adult men and women who were active or passive smokers | 515 mg | 60 days | — |
| Hypoxia/reoxygenation and vitamin C intake influence NO synthesis and antioxidant defenses of neutrophils 2004 · vitamin C-supplemented group · Seven professional apnea divers; sex and age not stated | 1 g | 7 days | — |
| The effects of vitamin C supplementation on serum concentrations of uric acid: results of a randomized controlled trial 2005 · vitamin C group · Nonsmoking participants; age and sex not specified, with no stated condition | 500 mg | 60 days | — |
| Ascorbic acid attenuates aspirin-induced gastric damage: role of inducible nitric oxide synthase 2006 · ASA-VitC · 10 young healthy Helicobacter pylori-positive volunteers | 960 mg | 3 days | — |
| Effects of vitamin C supplementation on antioxidants and lipid peroxidation markers in elderly subjects with type 2 diabetes 2009 · 0.5 g/day vitamin C · Elderly patients with type 2 diabetes mellitus | 500 mg | — | — |
| Effects of vitamin C supplementation on antioxidants and lipid peroxidation markers in elderly subjects with type 2 diabetes 2009 · 1 g/day vitamin C · Elderly patients with type 2 diabetes mellitus | 1 g | — | — |
| Effect of vitamin C on blood glucose, serum lipids & serum insulin in type 2 diabetes patients 2007 · 500 mg vitamin C group · Patients with type 2 diabetes; age and sex not reported | 500 mg | 6 weeks | — |
| Effect of vitamin C on blood glucose, serum lipids & serum insulin in type 2 diabetes patients 2007 · 1000 mg vitamin C group · Patients with type 2 diabetes; age and sex not reported | 1 g | 6 weeks | — |
| The effect of vitamins C and E on biomarkers of oxidative stress depends on baseline level 2008 · vitamin C tablet and placebo capsule · Adults aged 18 years or older; healthy nonsmokers without the listed excluded diseases | 1 g | 60 days | — |
| Lipoperoxidation and hemodialysis 2008 · vitamin C · Patients with end-stage renal disease starting hemodialysis; age and sex not reported | 1 g | 1 year | — |
| Vitamin C treatment reduces elevated C-reactive protein 2009 · Vitamin C group · Healthy nonsmokers; adults, mean age 44 years; not restricted to elevated CRP | 1 g | 60 days | — |
| Vitamin C supplementation lowers urinary levels of 4-hydroperoxy-2-nonenal metabolites in humans 2011 · Vitamin C supplementation · Men and women aged 18–35; healthy smokers smoking more than 10 cigarettes per day and nonsmokers | 1 g | 17 days | — |
| Effect of vitamin C supplementation on postprandial oxidative stress and lipid profile in type 2 diabetic patients 2011 · vitamin C treatment group · Adults with type 2 diabetes | 1 g | 6 weeks | — |
| Ascorbic acid supplementation improves skeletal muscle oxidative stress and insulin sensitivity in people with type 2 diabetes: Findings of a randomized controlled study 2016 · ascorbic acid (AA) supplementation · People with type 2 diabetes and stable glucose control; age and sex not stated | 1 g | 120 days | — |
| Investigating the effects of vitamins E and C on oxidative stress and hematological parameters among power plant workers: A double-blind randomized controlled clinical trial 2020 · vitamin C · Power plant employees; age and sex not reported | 1 g | 90 days | — |
| The effect of vitamin E and C on comet assay indices and apoptosis in power plant workers: A double blind randomized controlled clinical trial 2020 · Group 2 · Thermal power plant employees exposed to extremely low frequency electromagnetic fields; age and sex not reported | 1 g | — | — |
| The effect of vitamin C supplementation in the last month of pregnancy on neonatal bilirubin levels; A double-blind randomized clinical trial 2020 · intervention group · Healthy pregnant women aged 20–40 years, at 34 weeks of gestation | 500 mg | — | — |
| The Effects of Antioxidant Vitamins on Proinflammatory Cytokines and Some Biochemical Parameters of Power Plant Workers: A Double-Blind Randomized Controlled Clinical Trial 2021 · vitamin C group · Power plant workers exposed to extremely low-frequency magnetic fields (ELF-MFs); age and sex not reported | 1 g | 90 days | — |
| Eight Weeks of Vitamin C Supplementation Restores the Lost Correlation between Serum Leptin and C-reactive Protein (CRP) in Patients with Type 2 Diabetes; A Randomized, Double-blind, Parallel-group, Placebo-controlled Clinical Trial 2023 · Vitamin C group · Patients with longstanding type 2 diabetes mellitus; age and sex range not stated | 500 mg | 8 weeks | — |
| Vitamin C supplementation alleviates hypercortisolemia caused by chronic stress 2024 · Group I AA-treated subgroup · Female patients with functional hypercortisolemia due to chronic stress and elevated cortisol | 1 g | 60 days | — |
| Vitamin C supplementation alleviates hypercortisolemia caused by chronic stress 2024 · Group II AA-treated subgroup · Female patients with functional hypercortisolemia due to chronic stress and elevated cortisol and DHEA-S | 1 g | 60 days | — |
| Vitamin C supplementation alleviates hypercortisolemia caused by chronic stress 2024 · Group III AA-treated subgroup · Female patients with functional hypercortisolemia due to chronic stress, normal cortisol and elevated DHEA-S | 1 g | 60 days | — |
| Effect of vitamin C on lipoproteins in healthy adults 1994 · 1 g vitamin C · Healthy adults aged 17–74 years, both sexes | 1 g | 30 days | — |
| Effect of ascorbate supplementation on low density lipoprotein oxidation in smokers 1996 · ascorbate-supplemented group · healthy cigarette smokers | 1 g | 4 weeks | — |
| Vitamin E decreases urine lipid peroxidation products in young healthy human volunteers under normal conditions 1996 · 1 g of vitamin C · 21 young healthy men | 1 g | 30 days | — |
| The influence of antioxidant nutrients on platelet function in healthy volunteers 1997 · vitamin C · Healthy volunteers aged 20–50 years | 250 mg | 8 weeks | — |
| Administration of ascorbic acid and an aldose reductase inhibitor (tolrestat) in diabetes: effect on urinary albumin excretion 1998 · oral AA · Diabetic subjects; age and sex not reported | 1 g | 1 year | — |
| Supplementation of ascorbic acid and alpha-tocopherol is useful to preventing bone loss linked to oxidative stress in elderly 2010 · Tx1 · Older adults aged approximately 68 years, men and women, healthy or with controlled chronic disease | 500 mg | 1 year | 30 |
| Supplementation of ascorbic acid and alpha-tocopherol is useful to preventing bone loss linked to oxidative stress in elderly 2010 · Tx2 · Older adults aged approximately 69 years, men and women, healthy or with controlled chronic disease | 1 g | 1 year | 30 |
| Cardiovascular effects of oral Supplementation of vitamin C, E and folic acid in young healthy males 2004 · vitamin intervention · 31 young healthy male adults; 14 received the vitamin intervention | 1 g | 12 weeks | 14 |
| Effect of antioxidants combined to resistance training on BMD in elderly women: a pilot study 2009 · antioxidants · Postmenopausal women, mean age 66.1 years, described as healthy | 1 g | 26 weeks | 8 |
| Effect of antioxidants combined to resistance training on BMD in elderly women: a pilot study 2009 · exercise and antioxidants · Postmenopausal women, mean age 66.1 years, described as healthy | 1 g | 26 weeks | 8 |
| Decrease in oxidative stress through supplementation of vitamins C and E is associated with a reduction in blood pressure in patients with essential hypertension 2008 · vitamins C+E · Men aged 35–60 with grade 1 essential hypertension, without obesity, dyslipidaemia or diabetes | 1 g | 8 weeks | — |
| Effects of inorganic nitrate and vitamin C co-supplementation on blood pressure and vascular function in younger and older healthy adults: A randomised double-blind crossover trial 2020 · Nitrate and vitamin C · Healthy adults aged 18–40 years and 55–70 years | 20 mg/kg | 1 day | — |
| Effect of vitamin C and hawthorn beverage formula on blood pressure and oxidative stress in heat-exposed workers: a cluster-randomized controlled trial 2024 · intervention group · Heat-exposed workers; age and sex not reported | 130 mg | 40 days | — |
| Effect of vitamin C supplementation on oxidative stress and lipid profiles in hemodialysis patients 2009 · vitamin C group · Hemodialysis patients; age range and sex not stated | 125 mg | 12 weeks | 21 |
| Human skeletal muscle ascorbate is highly responsive to changes in vitamin C intake and plasma concentrations 2013 · high-dose group (2 kiwifruit/d) · Nonsmoking men aged 18–35 with below-average plasma ascorbate concentrations | 212 mg | 6 weeks | 18 |
| Effect of Omega-3 and Vitamins E + C Supplements on the Concentration of Serum B-Vitamins and Plasma Redox Aminothiol Antioxidant Status in Elderly Men after Strength Training for Three Months 2016 · group III · Healthy men, mean age 60 ± 6 years, undertaking strength training | 1 g | 90 days | 16 |
| Effects of acetylsalicylic acid on ascorbic acid concentrations in plasma, gastric mucosa, gastric juice and urine--a double-blind study in healthy subjects 2004 · ASC group · healthy subjects | 1.44 g | 6 days | 15 |
| Effects of acetylsalicylic acid on ascorbic acid concentrations in plasma, gastric mucosa, gastric juice and urine--a double-blind study in healthy subjects 2004 · ASA and ASC combination group · healthy subjects | 1.44 g | 6 days | 15 |
| A single high dose of ascorbic acid and iron is not correlated with oxidative stress in healthy volunteers 2008 · 2 g of AA · Healthy, nonsmoking men aged 20–31 years | 2 g | 1 day | 9 |
| A randomised cross-over pharmacokinetic bioavailability study of synthetic versus kiwifruit-derived vitamin C 2013 · kiwifruit · Non-smoking men aged 18–35 years with healthy baseline plasma vitamin C levels (>50 µmol/L) | 194 mg | 1 day | 9 |
| A randomised cross-over pharmacokinetic bioavailability study of synthetic versus kiwifruit-derived vitamin C 2013 · vitamin C tablets · Non-smoking men aged 18–35 years with healthy baseline plasma vitamin C levels (>50 µmol/L) | 196 mg | 1 day | 8 |
| Vitamin C pharmacokinetics of plain and slow release formulations in smokers 2004 · Plain-release group · Healthy men aged 20–65 years who smoked at least 5 cigarettes per day | 500 mg | 4 weeks | — |
| Vitamin C pharmacokinetics of plain and slow release formulations in smokers 2004 · Slow-release group · Healthy men aged 20–65 years who smoked at least 5 cigarettes per day | 500 mg | 4 weeks | — |
| Augmentation of respiratory tract lining fluid ascorbate concentrations through supplementation with vitamin C 2009 · 125 mg ascorbate group · Healthy subjects with low plasma ascorbate (<50 μM) | 125 mg | 2 weeks | — |
| Improvement in iron deficiency anemia through therapy with ferric ammonium citrate and vitamin C and the effects of aerobic exercise 1991 · Group II · Female college-student volunteers with iron-deficiency anemia or severe latent iron deficiency | 500 mg | 9 weeks | — |
| Improvement in iron deficiency anemia through therapy with ferric ammonium citrate and vitamin C and the effects of aerobic exercise 1991 · Group IV · Female college-student volunteers with iron-deficiency anemia or severe latent iron deficiency | 500 mg | 9 weeks | — |
| Plasma vitamin C and tocotrienols changes in response to dietary supplementation among young male adults 2010 · Combination · young male police recruits | 500 mg | 8 weeks | — |
| Combination oral antioxidant supplementation reduces blood pressure 1997 · antioxidants · Hypertensive and normotensive adult outpatients; 21 were attending for hypertension treatment and 17 were normotensive outpatients with minor gastrointestinal complaints. | 500 mg | 8 weeks | — |
| Vascular benefits of vitamin C supplementation against fine particulate air pollution in healthy adults: A double-blind randomised crossover trial 2022 · vitamin C supplementation group · healthy young adults exposed to fine particulate air pollution in Shijiazhuang, China | 2 g | 7 days | 58 |
| Cross-over study of influence of oral vitamin C supplementation on inflammatory status in maintenance hemodialysis patients 2013 · Group 2 · Adults over 18 with maintenance hemodialysis, low plasma vitamin C and high hs-CRP | 200 mg | 13 weeks | 52 |
| Ascorbate increases human oxaluria and kidney stone risk 2005 · Treatment A (ascorbic acid) · Stoneformers and age- and gender-matched non-stoneformers; ages not reported | 2 g | 6 days | 48 |
| Cross-over study of influence of oral vitamin C supplementation on inflammatory status in maintenance hemodialysis patients 2013 · Group 1 · Adults over 18 with maintenance hemodialysis, low plasma vitamin C and high hs-CRP | 200 mg | 13 weeks | 48 |
| Synchronizing positive effect of vitamin C and chromium on hyper lipidemia, hyperglycemia, liver enzymes and BMI of diabetes mellitus type 2 patients 2024 · treatment group · Adults with type 2 diabetes mellitus; age range and sex breakdown for this arm not specified | 500 mg | — | 30 |
| Effect of Beetroot Extract Supplementation on Serum Fatty Acid Profiles and Oxidative Stress Markers in Chronic Coronary Artery Disease Patients: A Secondary Analysis of a Randomized Controlled Trial 2025 · Group B: red beet + vitamin C · Adults aged 35–65 years with chronic coronary artery disease | 300 mg | 4 weeks | 30 |
| The effect of ascorbic acid supplementation on the blood lead levels of smokers 1999 · 200 mg ascorbic acid group · Men aged 20–30 who smoked at least one pack of cigarettes per day and had no clinical signs of ascorbic acid deficiency or lead toxicity | 200 mg | 4 weeks | 25 |
| Do iron and vitamin C co-supplementation influence platelet function or LDL oxidizability in healthy volunteers? 1999 · Group B · Healthy adult volunteers; sex and age range not stated | 260 mg | 12 weeks | 20 |
| Oral administration of ascorbic acid attenuates endothelial dysfunction after short-term cigarette smoking 2003 · ascorbic acid · Healthy subjects aged 28.7 ± 6.8 years who smoked a cigarette during the study | 2 g | 1 day | 19 |
| The effect of vitamin C supplementation on coagulability and lipid levels in healthy male subjects 2000 · Vitamin C · 18 healthy male volunteers with low-normal vitamin C levels | 2 g | — | 18 |
| Supplementation with cactus pear (Opuntia ficus-indica) fruit decreases oxidative stress in healthy humans: a comparative study with vitamin C 2004 · vitamin C · 18 healthy human volunteers | 150 mg | 2 weeks | 18 |
| The Administration of Resveratrol and Vitamin C Reduces Oxidative Stress in Postmenopausal Women-A Pilot Randomized Clinical Trial 2024 · Group B (resveratrol and vitamin C) · Women aged 50–60 with early postmenopause and insulin resistance | 500 mg | 90 days | 15 |
| Effect of ascorbic acid consumption on urinary stone risk factors 2003 · ascorbic acid phase, normal subjects · Normal subjects; age and sex not reported | 2 g | 6 days | 12 |
| Effect of ascorbic acid consumption on urinary stone risk factors 2003 · ascorbic acid phase, calcium oxalate stone formers · Calcium oxalate stone formers; age and sex not reported | 2 g | 6 days | 12 |
| Tropical fruit camu-camu (Myrciaria dubia) has anti-oxidative and anti-inflammatory properties 2008 · vitamin C group · male smokers; age not reported | 1.05 g | 7 days | 10 |
| Megadose of vitamin C delays insulin response to a glucose challenge in normoglycemic adults 1994 · Vitamin C (ascorbic acid) · Normoglycemic adults; mean age 22 ± 1 years | 2 g | 2 weeks | 9 |
| Effects of ascorbic acid and carbohydrate ingestion on exercise induced oxidative stress 1998 · vitamin C trial · Endurance athletes | 2 g | 1 day | 9 |
| Anti-Inflammatory, Antithrombotic and Antioxidant Efficacy and Synergy of a High-Dose Vitamin C Supplement Enriched with a Low Dose of Bioflavonoids; In Vitro Assessment and In Vivo Evaluation Through a Clinical Study in Healthy Subjects 2025 · VCF · Healthy volunteers; age and sex range not specified | 1 g | 4 weeks | 8 |
| Oral vitamins C and E as additional treatment in patients with acute anterior uveitis: a randomised double masked study in 145 patients 1999 · vitamin group · Patients with acute anterior uveitis; age and sex not specified | 1 g | 8 weeks | — |
| The effect of vitamin E and vitamin C supplementation on LDL oxidizability and neutrophil respiratory burst in young smokers 2000 · both vitamins · young smokers with a history of less than 5 pack-years | 1 g | 8 weeks | — |
| Long-term effects of vitamin E, vitamin C, and combined supplementation on urinary 7-hydro-8-oxo-2'-deoxyguanosine, serum cholesterol oxidation products, and oxidation resistance of lipids in nondepleted men 2000 · vitamin C and vitamin E combination · men described as nondepleted; age and condition not stated | 500 mg | 3 years | — |
| Potential problems of ascorbate and iron supplementation: pro-oxidant effect in vivo? 2000 · 260 mg/d ascorbate plus 14 mg/d iron · 20 healthy subjects | 260 mg | 6 weeks | — |
| Supplementation with vitamin E but not with vitamin C lowers lipid peroxidation in vivo in mildly hypercholesterolemic men 2001 · both vitamins group (CellaVie) · Clinically healthy men with mild hypercholesterolemia and normal vitamin C and E levels | 500 mg | 1 year | — |
| A randomized, double-blind, controlled trial of vitamin C in the management of hypertension and lipids 2002 · 2000 mg vitamin C · Adults with mild hypertension; mean age 62 years; 52% men | 2 g | 26 weeks | — |
| Effects of antioxidant vitamins C and E on endothelial function and thrombosis/fibrinolysis system in smokers 2003 · group A · Healthy smokers; age range and sex not reported | 2 g | 4 weeks | — |
| Coronary vasoregulation in patients with various risk factors in response to cold pressor testing: contrasting myocardial blood flow responses to short- and long-term vitamin C administration 2003 · Long-term vitamin C supplementation · Adults with normal coronary angiograms and hypertension, smoking, or hypercholesterolemia | 2 g | 2 years | — |
| Effect of ascorbic acid supplementation on the sperm quality of smokers 1992 · 200 mg group · Men aged 20–35 who were heavy smokers | 200 mg | 30 days | — |
| Vitamin C affects thrombosis/ fibrinolysis system and reactive hyperemia in patients with type 2 diabetes and coronary artery disease 2003 · Vitamin C · Patients with type 2 diabetes and coronary artery disease; age and sex not specified | 2 g | 4 weeks | — |
| Effects of combined administration of vitamins C and E on reactive hyperemia and inflammatory process in chronic smokers 2003 · group A · Healthy young chronic smokers; age and sex not specified | 2 g | 4 weeks | — |
| Vitamin C supplementation decreases oxidative DNA damage in mononuclear blood cells of smokers 2004 · Slow-release vitamin C with plain-release vitamin E · Male smokers | 500 mg | 4 weeks | — |
| Vitamin C supplementation decreases oxidative DNA damage in mononuclear blood cells of smokers 2004 · Plain-release vitamin C with plain-release vitamin E · Male smokers | 500 mg | 4 weeks | — |
| [Study the effect of antioxidant vitamin E, vitamin C and beta-carotene supplement on erythrocyte functions in elderly person] 2008 · Group 4 · Adults aged 60–75 years; elderly participants | 300 mg | 16 weeks | — |
| Vitamin C supplementation and salivary immune function following exercise-heat stress 2008 · VC group · Healthy individuals exposed to prolonged cycling exercise in hot conditions | 1.5 g | 12 days | — |
| Randomized placebo-controlled trial of guava juice as a source of ascorbic acid to reduce iron deficiency in Tarahumara indigenous schoolchildren of northern Mexico 2011 · Guava juice · Tarahumara boarding-school children aged 6–9 years with mild iron deficiency anemia | 200 mg | 10 weeks | — |
| The evaluation of protective and mitigating effects of vitamin C against side effects induced by radioiodine therapy 2018 · Group 2 · Patients with differentiated thyroid cancer undergoing radioiodine therapy; age and sex not stated | 1.5 g | — | — |
| The evaluation of protective and mitigating effects of vitamin C against side effects induced by radioiodine therapy 2018 · Group 3 · Patients with differentiated thyroid cancer undergoing radioiodine therapy; age and sex not stated | 1.5 g | 4 days | — |
| The evaluation of protective and mitigating effects of vitamin C against side effects induced by radioiodine therapy 2018 · Group 4 · Patients with differentiated thyroid cancer undergoing radioiodine therapy; age and sex not stated | 1.5 g | — | — |
| Effect of vitamin C on lipoproteins in healthy adults 1994 · 2 g vitamin C · Healthy adults aged 17–74 years, both sexes | 2 g | 30 days | — |
| Magnesium and ascorbic acid supplementation in diabetes mellitus 1995 · AA supplementation · Outpatients with diabetes mellitus; reported beneficial outcomes were among subjects with non-insulin-dependent diabetes mellitus | 2 g | 90 days | — |
| Modulation of oxidant stress in vivo in chronic cigarette smokers 1996 · vitamin C · Chronic cigarette smokers; age and sex not reported | 2 g | 5 days | — |
| Effect of five-year supplementation of vitamin C on serum vitamin C concentration and consumption of vegetables and fruits in middle-aged Japanese: a randomized controlled trial 2003 · 50 mg/day vitamin C group · Middle-aged Japanese adults with atrophic gastritis | 50 mg | 1826 days | 120 |
| Partial resistance of low density lipoprotein to oxidation in vivo after increased intake of berries 2000 · supplement group · Healthy 60-year-old men | 500 mg | 8 weeks | 20 |
| Human skeletal muscle ascorbate is highly responsive to changes in vitamin C intake and plasma concentrations 2013 · low-dose group (0.5 kiwifruit/d) · Nonsmoking men aged 18–35 with below-average plasma ascorbate concentrations | 53 mg | 6 weeks | 18 |
| A randomized steady-state bioavailability study of synthetic versus natural (kiwifruit-derived) vitamin C 2013 · Vitamin C tablet group · Men aged 18–35 with below-average plasma ascorbate levels | 52 mg | 6 weeks | 18 |
| Effects of three-month oral supplementation of beta-carotene and vitamin C on serum concentrations of carotenoids and vitamins in middle-aged subjects: a pilot study for a randomized controlled trial to prevent gastric cancer in high-risk Japanese population 2000 · Low-dose vitamin C group · Adults aged 40–69 with chronic atrophic gastritis | 50 mg | 90 days | 16 |
| Comparative Bioavailability of Vitamin C After Short-Term Consumption of Raw Fruits and Vegetables and Their Juices: A Randomized Crossover Study 2025 · A group (vitamin C supplement) · Healthy adult men and women; ages not reported | 102 mg | 1 day | 12 |
| Effect of an 8-weeks aerobic training program in elderly on oxidative stress and HSP72 expression in leukocytes during antioxidant supplementation 2012 · antioxidant supplemented sedentary group (AS) · Healthy septuagenarians, men and women, mean age 73.4 years; no stated disease or nutrient deficiency. | 500 mg | 8 weeks | 8 |
| Effect of an 8-weeks aerobic training program in elderly on oxidative stress and HSP72 expression in leukocytes during antioxidant supplementation 2012 · antioxidant supplemented and aerobically trained group (AT) · Healthy septuagenarians, men and women, mean age 75.8 years; no stated disease or nutrient deficiency. | 500 mg | 8 weeks | 8 |
| GLV supplements increased plasma beta-carotene, vitamin C, zinc and hemoglobin in young healthy adults 2006 · spinach-carrot meal · Young healthy adults; sex and age range not reported | 130 mg | 1 day | 4 |
| New evidence for antioxidant properties of vitamin C 2000 · 5,000 mg ascorbic acid · Healthy volunteers; age and sex not specified | 5 g | 2 weeks | — |
| [Bases to determine the dose of vitamin C in pregnancy] 2005 · Vitamin C 100 mg/day · Women studied from week 20 to week 32 of pregnancy | 100 mg | 12 weeks | — |
| Combination treatment with high-dose vitamin C and alpha-tocopherol does not enhance respiratory-tract lining fluid vitamin C levels in asthmatics 2009 · 500 mg tocopherol and 2 g vitamin C · Adults aged 18–50 with allergic moderate-to-severe persistent asthma | 2 g | 12 weeks | — |
| Augmentation of respiratory tract lining fluid ascorbate concentrations through supplementation with vitamin C 2009 · 60 mg/day vitamin C group · Healthy subjects with low plasma ascorbate (<50 μM) | 60 mg | 2 weeks | — |
| Effect of mixed flavonoids, n-3 fatty acids, and vitamin C on oxidative stress and antioxidant capacity before and after intense cycling 2011 · QC · Athletes; age and sex not specified | 1 g | 17 days | — |
| In overweight and obese women, dietary iron absorption is reduced and the enhancement of iron absorption by ascorbic acid is one-half that in normal-weight women 2015 · +AA meal · Healthy, nonanemic women aged unspecified, including normal-weight, overweight and obese women | 31.4 mg | 1 day | — |
| Vitamin C-Rich Guava Consumed with Mungbean Dal Reduces Anemia and Increases Hemoglobin but not Iron Stores: A Randomized Controlled Trial of Food-to-Food Fortification in Indian Children 2024 · mungbean dal with fresh guava · Children aged 6–10 years in rural Haryana, India; the group included children with and without anemia or iron deficiency | 170 mg | 213 days | — |
| The bioavailability to humans of ascorbic acid from oranges, orange juice and cooked broccoli is similar to that of synthetic ascorbic acid 1993 · Ascorbic acid tablets without iron · Male non-smokers; age and health status not specified | 108 mg | 8 weeks | — |
| Modulation of UV-light-induced skin inflammation by D-alpha-tocopherol and L-ascorbic acid: a clinical study using solar simulated radiation 1998 · Group (2) · Healthy volunteers | 3 g | 50 days | — |
| The effect of 5-year vitamin C supplementation on serum pepsinogen level and Helicobacter pylori infection 2003 · low-dose group · Adults aged 40–69 with chronic gastritis in a high-risk area for gastric cancer in Japan | 50 mg | 5 years | 120 |
| Does vitamin C cause hemolysis in premature newborn infants? Results of a multicenter double-blind, randomized, controlled trial 1997 · vitamin C · Premature neonates with birth weight 1000 to 1500 g | 50 mg | 2 weeks | 32 |
| [Synergistic antioxidative effect of vitamins E and C on low density lipoproteins from smokers and non-smokers subjects] 2004 · vitamins E and C combination · 20 healthy adult smokers and 10 healthy adult non-smokers | 1 g | 30 days | 30 |
| Role of vitamin C as an adjuvant therapy to different iron chelators in young β-thalassemia major patients: efficacy and safety in relation to tissue iron overload 2016 · DFO-treated patients receiving vitamin C · Young vitamin C-deficient patients with β-thalassemia major and moderate iron overload receiving deferoxamine | 100 mg | 1 year | 30 |
| Role of vitamin C as an adjuvant therapy to different iron chelators in young β-thalassemia major patients: efficacy and safety in relation to tissue iron overload 2016 · DFP-treated patients receiving vitamin C · Young vitamin C-deficient patients with β-thalassemia major and moderate iron overload receiving deferiprone | 100 mg | 1 year | 30 |
| Role of vitamin C as an adjuvant therapy to different iron chelators in young β-thalassemia major patients: efficacy and safety in relation to tissue iron overload 2016 · DFX-treated patients receiving vitamin C · Young vitamin C-deficient patients with β-thalassemia major and moderate iron overload receiving deferasirox | 100 mg | 1 year | 30 |
| The impact of vitamin and/or mineral supplementation on lipid profiles in type 2 diabetes 2004 · group V · Adults with type 2 diabetes; age and sex not reported | 200 mg | 90 days | 18 |
| Usefulness of Antioxidants as Adjuvant Therapy for Septic Shock: A Randomized Clinical Trial 2020 · Vit C · Adults of either sex with septic shock | 4 mg | 5 days | 18 |
| Vitamin E and C supplementation prevents decrease of eicosapentaenoic acid in mononuclear cells in chronic hepatitis C patients during combination therapy of interferon alpha-2b and ribavirin 2006 · vitamin group · Patients with chronic hepatitis C receiving interferon-alpha-2b and ribavirin combination therapy; age and sex not reported | 750 mg | 8 weeks | 14 |
| Zinc supplementation prevents the increase of transaminase in chronic hepatitis C patients during combination therapy with pegylated interferon alpha-2b and ribavirin 2007 · control group · Patients with chronic hepatitis C receiving pegylated interferon alpha-2b and ribavirin therapy | 600 mg | 48 weeks | 12 |
| Effects of colon-targeted vitamins on the composition and metabolic activity of the human gut microbiome- a pilot study 2021 · Vitamin B2 + C · Healthy adult volunteers; age and sex range not specified | 500 mg | 4 weeks | 12 |
| Antioxidant supplementation prevents exercise-induced lipid peroxidation, but not inflammation, in ultramarathon runners 2004 · antioxidants (AO) · Ultramarathon runners participating in a 50 km race; age and sex distribution not reported | 1 g | 6 weeks | 11 |
| Supplementation with vitamins C and E enhances cytokine production by peripheral blood mononuclear cells in healthy adults 1996 · vitamins C and E group · healthy adults; age range and sex not reported | 1 g | 4 weeks | 10 |
| Increased serum and low-density-lipoprotein antioxidant potential after antioxidant supplementation in endurance athletes 1997 · antioxidant trial · Eight endurance athletes | 1 g | 4 weeks | 8 |
| Orange juice vs vitamin C: effect on hydrogen peroxide-induced DNA damage in mononuclear blood cells 2007 · blood orange juice (BOJ) · young healthy adults; sex not reported | 150 mg | 1 day | 7 |
| Platelet nitric oxide and superoxide release during the development of nitrate tolerance: effect of supplemental ascorbate 2002 · NTG/ascorbate · People whose age, sex, and health condition are not specified | 2.4 g | 3 days | — |
| Orange juice ingestion and supplemental vitamin C are equally effective at reducing plasma lipid peroxidation in healthy adult women 2003 · vitamin C supplement treatment · Healthy adult women; mean age 28.6 years | 70 mg | 2 weeks | — |
| The effect of iron-vitamin C co-supplementation on biomarkers of oxidative stress in iron-deficient female youth 2013 · 50 mg/day elemental iron + 500 mg/day ascorbic acid · Iron-deficient, non-anemic girls | 500 mg | 12 weeks | — |
| Ascorbate is depleted by smoking and repleted by moderate supplementation: a study in male smokers and nonsmokers with matched dietary antioxidant intakes 2000 · nonsmokers receiving vitamin cocktail · Male nonsmokers selected for low fruit and vegetable intake | 272 mg | 90 days | 38 |
| Ascorbate is depleted by smoking and repleted by moderate supplementation: a study in male smokers and nonsmokers with matched dietary antioxidant intakes 2000 · smokers receiving vitamin cocktail · Male smokers selected for low fruit and vegetable intake | 272 mg | 90 days | 37 |
| Oral Supplementation with Sucrosomial Ferric Pyrophosphate Plus L-Ascorbic Acid to Ameliorate the Martial Status: A Randomized Controlled Trial 2020 · intervention group · Adults aged 18–80 undergoing elective hip or knee replacement | 70 mg | 30 days | 37 |
| Adjunctive intravenous then oral vitamin C for moderate and severe community-acquired pneumonia in hospitalized adults: feasibility of randomized controlled trial 2023 · Vitamin C · Adults aged 18 years or older hospitalized with moderate or severe community-acquired pneumonia | 3 g | — | 36 |
| Iron deficiency in young basketball players: Is a 100 μg/L ferritin cut-off appropriate for iron supplementation?: Results of a randomized placebo-controlled study 2023 · iron supplementation group · male basketball players under 19 years with ferritin below 100 μg/L | 30 mg | 90 days | 26 |
| Oral use of iron with vitamin C in hemodialyzed patients 2003 · Sorbifer Durules · Adults with end-stage renal disease receiving hemodialysis and recombinant human erythropoietin | 60 mg | 4 weeks | 24 |
| Antioxidant supplementation enhances antioxidant capacity and mitigates oxidative damage following acute ischaemic stroke 2005 · Treatment group · Acute ischaemic stroke patients treated within 12 hours of symptom onset | 500 mg | 2 weeks | 24 |
| Faster plasma vitamin E disappearance in smokers is normalized by vitamin C supplementation 2006 · Ascorbic acid supplementation · Adult cigarette smokers and nonsmokers; smokers (n=11) and nonsmokers (n=13) | 1 g | 2 weeks | 24 |
| Antioxidant supplementation with or without B-group vitamins after acute ischemic stroke: a randomized controlled trial 2006 · Antioxidant vitamins · Acute ischemic stroke patients treated within 12 hours of symptom onset | 500 mg | 2 weeks | 24 |
| Effects of l-Arginine Plus Vitamin C Supplementation on l-Arginine Metabolism in Adults with Long COVID: Secondary Analysis of a Randomized Clinical Trial 2023 · l-arginine plus vitamin C · Men and women aged 20–60 with long COVID and persistent fatigue after confirmed SARS-CoV-2 infection | 1 g | 4 weeks | 23 |
| Iron absorption from a breakfast cereal: effects of EDTA compounds and ascorbic acid 2001 · Hydrogen reduced iron plus ascorbic acid · Non-anaemic female volunteers | 15 mg | 2 days | 20 |
| Supplementation with antioxidants prior to bone marrow transplantation 1997 · BMT(+) · Bone marrow transplant patients receiving conditioning therapy | 450 mg | 3 weeks | 16 |
| Can changes in hydrophobicity increase the bioavailability of alpha-tocopherol? 2006 · Nutritional supplement sucked (d0) · Adults aged 22.7–35.3 years, both sexes; no condition stated | 400 mg | 1 day | 14 |
| Can changes in hydrophobicity increase the bioavailability of alpha-tocopherol? 2006 · Nutritional supplement swallowed (d10) · Adults aged 22.7–35.3 years, both sexes; no condition stated | 400 mg | 1 day | 14 |
| The response of gamma vitamin E to varying dosages of alpha vitamin E plus vitamin C 2009 · low dose vitamins · Adults with well-controlled, non-insulin-requiring type 2 diabetes; men and women, mean age 53 years | 250 mg | 2 weeks | 12 |
| The response of gamma vitamin E to varying dosages of alpha vitamin E plus vitamin C 2009 · medium dose vitamins · Adults with well-controlled, non-insulin-requiring type 2 diabetes; men and women, mean age 53 years | 500 mg | 2 weeks | 12 |
| The response of gamma vitamin E to varying dosages of alpha vitamin E plus vitamin C 2009 · high dose vitamins · Adults with well-controlled, non-insulin-requiring type 2 diabetes; men and women, mean age 53 years | 1 g | 2 weeks | 12 |
| Effect of Vitamin C and Protein Supplementation on Plasma Nitrate and Nitrite Response following Consumption of Beetroot Juice 2022 · Beet It Sport plus vitamin C · Healthy adults aged 40–80 years | 500 mg | 1 day | 12 |
| Iron bioavailability in infants from an infant cereal fortified with ferric pyrophosphate or ferrous fumarate 2000 · [57Fe]ferrous fumarate with 25 mg ascorbic acid (study 2) · Infants; age and health status not reported | 25 mg | 4 days | 9 |
| Iron bioavailability in infants from an infant cereal fortified with ferric pyrophosphate or ferrous fumarate 2000 · [57Fe]ferrous fumarate with 50 mg ascorbic acid (study 2) · Infants; age and health status not reported | 50 mg | 4 days | 9 |
| L-ascorbic acid improves the serum folate response to an oral dose of [6S]-5-methyltetrahydrofolic acid in healthy men 2008 · 343 microg [6S]-5-CH(3)H(4)PteGlu with 289.4 mg L-AA · healthy men | 289 mg | 1 day | 9 |
| L-ascorbic acid improves the serum folate response to an oral dose of [6S]-5-methyltetrahydrofolic acid in healthy men 2008 · 343 microg [6S]-5-CH(3)H(4)PteGlu with 973.8 mg L-AA · healthy men | 974 mg | 1 day | 9 |
| A single high dose of ascorbic acid and iron is not correlated with oxidative stress in healthy volunteers 2008 · 2 g of AA plus 150 mg of iron carbonyl · Healthy, nonsmoking men aged 20–31 years | 2 g | 1 day | 9 |
| Iron bioavailability in infants from an infant cereal fortified with ferric pyrophosphate or ferrous fumarate 2000 · [57Fe]ferric pyrophosphate with 25 mg ascorbic acid (study 1) · Infants; age and health status not reported | 25 mg | 4 days | 8 |
| Iron bioavailability in infants from an infant cereal fortified with ferric pyrophosphate or ferrous fumarate 2000 · [57Fe]ferrous fumarate with 25 mg ascorbic acid (study 1) · Infants; age and health status not reported | 25 mg | 4 days | 8 |
| GLV supplements increased plasma beta-carotene, vitamin C, zinc and hemoglobin in young healthy adults 2006 · standard meal with tablets · Young healthy adults; sex and age range not reported | 150 mg | 1 day | 4 |
| Effect of folic acid and vitamin C supplementation on folate status and homocysteine level: a randomised controlled trial in Italian smoker-blood donors 2002 · C: folic acid plus vitamin C · Italian repeat blood donors who smoked more than 15 cigarettes per day; age and sex not specified | 500 mg | 45 days | — |
| Comparison of the effects of simultaneous administration of vitamin C and omega-3 fatty acids on lipoproteins, apo A-I, apo B, and malondialdehyde in hyperlipidemic patients 2003 · VitC + n-3FAs group · Hyperlipidemic patients with total cholesterol and triglycerides greater than 200 mg/dL; age and sex not specified | 500 mg | 10 weeks | — |
| Effects of maternal antioxidant supplementation on maternal and fetal antioxidant levels: a randomized, double-blind study 2003 · Supplemented women · Pregnant women starting supplementation at 35 weeks' gestation | 500 mg | — | — |
| Differential response of plasma and immune cell's vitamin E levels to physical activity and antioxidant vitamin supplementation 2005 · supplemented group · trained male amateur runners aged 32–36 years who participated in a half-marathon | 152 mg | 30 days | — |
| Antioxidant vitamin supplementation prevents oxidative stress but does not enhance performance in young football athletes 2019 · antioxidant-supplemented · Young football athletes; age and sex not specified | 500 mg | 15 days | — |
| High-dose vitamin C supplementation in patients undergoing allogeneic hematopoietic stem cell transplantation: A pilot randomized, triple-blind, placebo-controlled trial 2026 · Vitamin C group · Adult patients with hematological disorders undergoing allogeneic hematopoietic stem cell transplantation | 500 mg | 100 days | — |
| Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin 1995 · Chromagen · Dialysis patients receiving recombinant human erythropoietin | 100 mg | 26 weeks | — |
| Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin 1995 · Feosol · Dialysis patients receiving recombinant human erythropoietin | 100 mg | 26 weeks | — |
| Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin 1995 · Niferex · Dialysis patients receiving recombinant human erythropoietin | 100 mg | 26 weeks | — |
| Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin 1995 · Tabron · Dialysis patients receiving recombinant human erythropoietin | 100 mg | 26 weeks | — |
| The bioavailability to humans of ascorbic acid from oranges, orange juice and cooked broccoli is similar to that of synthetic ascorbic acid 1993 · Ascorbic acid tablets with iron · Male non-smokers; age and health status not specified | 108 mg | 8 weeks | — |
| Antioxidants, Helicobacter pylori and stomach cancer in Venezuela 1996 · Treatment 1 · People with precancerous stomach lesions, including chronic gastritis, chronic atrophic gastritis, intestinal metaplasia or dysplasia; age and sex not specified | 750 mg | 7 days | — |
| Effect of 6 month supplementation with different combinations of an association of antioxidant nutrients on biochemical parameters and markers of the antioxidant defence system in the elderly. The Geriatrie/Min.Vit.Aox Network 1996 · V (vitamins) · Elderly nursing-home residents aged 65–103 years who were long-term hospitalized | 120 mg | 26 weeks | — |
| Effect of a two-year supplementation with low doses of antioxidant vitamins and/or minerals in elderly subjects on levels of nutrients and antioxidant defense parameters 1997 · vitamin group · Hospitalized adults older than 65 years; baseline vitamin C deficiency was common | 120 mg | 2 years | — |
| Effects of trace element and/or vitamin supplementation on vitamin and mineral status, free radical metabolism and immunological markers in elderly long term-hospitalized subjects. Geriatric Network MIN. VIT. AOX 1997 · vitamins · Institutionalized elderly subjects in long-term hospital or nursing-home care | 120 mg | 1 year | — |
| Personalized Cardio-Metabolic Responses to an Anti-Inflammatory Nutrition Intervention in Obese Adolescents: A Randomized Controlled Crossover Trial 2018 · Anti-inflammatory nutrition supplement (AINS) · Overweight and obese adolescents aged 13–18 years | 567 mg | 8 weeks | 70 |
| The impact of vitamin and/or mineral supplementation on lipid profiles in type 2 diabetes 2004 · group MV · Adults with type 2 diabetes; age and sex not reported | 200 mg | 90 days | 17 |
| Impact of multiple genetic polymorphisms on effects of a 4-week blueberry juice intervention on ex vivo induced lymphocytic DNA damage in human volunteers 2007 · blueberry/apple juice intervention · 168 healthy human volunteers; age and sex not reported | 16 mg | 4 weeks | 168 |
| The effect of Lactiplantibacillus plantarum 299v together with a low dose of iron on iron status in healthy pregnant women: A randomized clinical trial 2021 · Lp group · Healthy, non-anemic pregnant women aged 18–42 years, with singleton pregnancies and iron-replete status at enrollment | 24 mg | — | 120 |
| The Effect of Maternal Antioxidant Vitamin Supplementation on Maternal and Cord Blood Adiponectin Concentrations 2025 · vitamin supplementation group · Pregnant nulliparous participants enrolled at 9–16 weeks’ gestation, without pregestational diabetes or gestational diabetes | 1 g | — | 98 |
| Supplementation with antioxidant micronutrients in pregnant women with obesity: a randomized controlled trial 2024 · Intervention group · Pregnant women with obesity (BMI ≥30 kg/m²) | 90 mg | — | 64 |
| Effects of Multivitamin, Multimineral and Phytonutrient Supplementation on Nutrient Status and Biomarkers of Heart Health Risk in a Russian Population: A Randomized, Double Blind, Placebo Controlled Study 2018 · VMP (Nutrilite Double X™) · Generally healthy adults aged 40–70 years in Moscow with low habitual recommended-food intake (recommended food score <12), predominantly women; no chronic diseases | 180 mg | 8 weeks | 60 |
| Trace element supplementation in hemodialysis patients: a randomized controlled trial 2015 · medium dose · Adults aged 18 years or older on maintenance hemodialysis, with end-stage kidney disease | 100 mg | 180 days | 52 |
| [Effects of vitamins E, C and beta-carotene on DNA damage] 1999 · trial group · Healthy men aged 50–59 years | 100 mg | 20 weeks | 50 |
| Role of antioxidants in reducing oxidative stress and seizure frequency in drug-resistant epileptic patients 2024 · treatment group · Children aged 1–18 years with drug-resistant epilepsy | 100 mg | 8 weeks | 50 |
| Trace element supplementation in hemodialysis patients: a randomized controlled trial 2015 · low dose · Adults aged 18 years or older on maintenance hemodialysis, with end-stage kidney disease | 100 mg | 180 days | 47 |
| Effects of antioxidant supplementation on postprandial oxidative stress and endothelial dysfunction: a single-blind, 15-day clinical trial in patients with untreated type 2 diabetes, subjects with impaired glucose tolerance, and healthy controls 2005 · type 2 diabetes group · Adults with early-stage, untreated type 2 diabetes | 250 mg | 15 days | 46 |
| Effects of antioxidant supplementation on postprandial oxidative stress and endothelial dysfunction: a single-blind, 15-day clinical trial in patients with untreated type 2 diabetes, subjects with impaired glucose tolerance, and healthy controls 2005 · impaired glucose tolerance group · Adults with impaired glucose tolerance | 250 mg | 15 days | 46 |
| Effects of antioxidant supplementation on postprandial oxidative stress and endothelial dysfunction: a single-blind, 15-day clinical trial in patients with untreated type 2 diabetes, subjects with impaired glucose tolerance, and healthy controls 2005 · healthy control group · Healthy adults | 250 mg | 15 days | 46 |
| Safety and immunogenicity of a live oral recombinant cholera vaccine VA1.4: a randomized, placebo controlled trial in healthy adults in a cholera endemic area in Kolkata, India 2014 · Vaccine group · Healthy adults aged 18–60 years living in Kolkata, India | 1.65 g | 2 weeks | 44 |
| Safety and immunogenicity of a live oral recombinant cholera vaccine VA1.4: a randomized, placebo controlled trial in healthy adults in a cholera endemic area in Kolkata, India 2014 · Placebo group · Healthy adults aged 18–60 years living in Kolkata, India | 1.65 g | 2 weeks | 44 |
| Impact of vitamin E and C supplementation on serum adhesion molecules in chronic degenerative aortic stenosis: a randomized controlled trial 2005 · vitamin E and vitamin C group · Patients with asymptomatic or mildly symptomatic moderate chronic degenerative aortic stenosis, with or without concomitant coronary artery disease; age and sex not reported | 1 g | 26 weeks | 41 |
| Pharmacokinetic Analyses of Liposomal and Non-Liposomal Multivitamin/Mineral Formulations 2023 · Non-liposomal multivitamin (NL) · Healthy males and females aged 18–65 years | 110 mg | 1 day | 34 |
| Pharmacokinetic Analyses of Liposomal and Non-Liposomal Multivitamin/Mineral Formulations 2023 · Liposomal multivitamin (L) · Healthy males and females aged 18–65 years | 110 mg | 1 day | 34 |
| Micronutrient deficiency in obese subjects undergoing low calorie diet 2012 · LCD intervention group (low-calorie formula diet) · Adults with obesity (BMI ≥30 kg/m²), men and women; age approximately 47 years on average | 100 mg | 12 weeks | 32 |
| Rapid recovery time of hemoglobin level in female regular blood donors with ferrous fumarate and high dose of ascorbic acid supplement 2013 · Group II · Female regular blood donors; age range and health conditions beyond regular blood donation not specified | 100 mg | 30 days | 32 |
| Rapid recovery time of hemoglobin level in female regular blood donors with ferrous fumarate and high dose of ascorbic acid supplement 2013 · Group III · Female regular blood donors; age range and health conditions beyond regular blood donation not specified | 500 mg | 30 days | 32 |
| Double-blind, randomised study of the effect of combined treatment with vitamin C and E on albuminuria in Type 2 diabetic patients 2001 · combined vitamin C and E treatment · Adults with type 2 diabetes and persistent micro/macroalbuminuria (urinary albumin excretion rate 30–300 mg/24 h) | 1.25 g | 4 weeks | 30 |
| The Effect of Combined Vitamin C and Vitamin E Supplementation on Oxidative Stress Markers in Women with Endometriosis: A Randomized, Triple-Blind Placebo-Controlled Clinical Trial 2021 · Group A · Women aged 15–45 with pelvic pain and laparoscopically confirmed stage 1–3 endometriosis | 1 g | 8 weeks | 30 |
| Management of fatty liver disease with vitamin E and C compared to ursodeoxycholic acid treatment 2005 · vitamin E plus vitamin C combination · Patients with histologically proven fatty liver disease and chronically elevated alanine aminotransferase despite a three-month reducing diet; age and sex distribution not stated | 500 mg | 26 weeks | 28 |
| High 15-F2t-Isoprostane Levels in Patients with a Previous History of Nonmelanoma Skin Cancer: The Effects of Supplementary Antioxidant Therapy 2015 · supplemented group · Adults aged 20 years or older with a previous history of nonmelanoma skin cancer treated by surgery | 500 mg | 60 days | 26 |
| Effects of vitamin E and C supplementation on oxidative stress and viral load in HIV-infected subjects 1998 · vitamin group · HIV-positive patients; age and sex not specified | 1 g | 90 days | 26 |
| Soy isoflavones improve bone metabolism in postmenopausal Japanese women 2004 · V · Women; a subgroup of the study participants was postmenopausal | 25 mg | 4 weeks | 24 |
| Antioxidant supplementation with or without B-group vitamins after acute ischemic stroke: a randomized controlled trial 2006 · Antioxidant vitamins plus B-group vitamins · Acute ischemic stroke patients treated within 12 hours of symptom onset | 500 mg | 2 weeks | 24 |
| Antioxidants restore protoporphyrinogen oxidase in variegate porphyria patients 2013 · vitamins E and C treatment phase · 12 women with variegate porphyria and 12 control women | 150 mg | 26 weeks | 24 |
| Fortified whey beverage for improving muscle mass in chronic obstructive pulmonary disease: a single-blind, randomized clinical trial 2020 · intervention group · Men aged 50–70 with moderate-to-severe COPD and BMI below 25 | 685 mg | 8 weeks | 23 |
| Antioxidant vitamins and low-density-lipoprotein oxidation 1993 · antioxidant supplementation · Adults; ages and health conditions not stated | 900 mg | 26 weeks | 22 |
| [A randomized single-blind trial of the effects of vitamins C and E in familial hypercholesterolemia] 2006 · vitamin therapy group · Girls and boys aged 2–18 years with heterozygous familial hypercholesterolemia and LDL-cholesterol above 160 mg/dl | 1 g | 1 year | 21 |
| Boosting Antioxidant Defense: The Effect of Astaxantin on Superoxidase Dismutase and Malondialdehyde Reduction in Patients with Head and Neck Cancer Receiving Cisplatin Chemotherapy 2024 · Vitamin C and E group · Patients aged over 11 and under 80 with stage II–IV head and neck cancer receiving cisplatin chemotherapy; males and females | 500 mg | 3 weeks | 21 |
| Do iron and vitamin C co-supplementation influence platelet function or LDL oxidizability in healthy volunteers? 1999 · Group A · Healthy adult volunteers; sex and age range not stated | 60 mg | 12 weeks | 20 |
| Antioxidant therapy for recurrent pancreatitis: biochemical profiles in a placebo-controlled trial 1992 · active treatment · Patients with recurrent non-gallstone pancreatitis | 540 mg | 10 weeks | 20 |
| Redox-regulation of haemostasis in hypoxic exercising humans: a randomised double-blind placebo-controlled antioxidant study 2018 · antioxidant group · Healthy males | 1 g | 8 weeks | 20 |
| Ultraviolet radiation-induced degradation of dermal extracellular matrix and protection by green tea catechins: a randomized controlled trial 2022 · green tea catechins (GTC) group · Healthy white adults aged 18–65 years with Fitzpatrick sun-reactive skin types I–II | 50 mg | 12 weeks | 20 |
| Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial 2002 · vitamin group · cardiac transplant recipients 0–2 years after transplantation | 1 g | 1 year | 19 |
| Influence of vitamin C and E supplementation on oxidative stress induced by hyperbaric oxygen in healthy men 2006 · Daily vitamin C and vitamin E supplementation · Healthy men | 500 mg | 4 weeks | 19 |
| Comparison of the effects of vitamins and/or mineral supplementation on glomerular and tubular dysfunction in type 2 diabetes 2005 · group V · Patients with type 2 diabetes; age range and sex not specified | 200 mg | 90 days | 18 |
| [Effect of antioxidant use in dietary therapy in patients with chronic athrofic hastritis] 2006 · antioxidant complex · Patients with gastric premalignant lesions, including intestinal metaplasia; age and sex not reported | 2.1 g | 1 year | 18 |
| Oxidative stress response to aerobic exercise: comparison of antioxidant supplements 2006 · V treatment · Aerobically trained men and women | 1 g | 2 weeks | 15 |
| Bioavailability of AREDS1 micronutrients from softgel capsules and tablets: a pilot study 2014 · softgel half-dose (single softgel) · Healthy adults aged 18–45 years, women and men | 226 mg | 1 day | 15 |
| Bioavailability of AREDS1 micronutrients from softgel capsules and tablets: a pilot study 2014 · softgel full-dose (two softgels) · Healthy adults aged 18–45 years, women and men | 452 mg | 1 day | 15 |
| Bioavailability of AREDS1 micronutrients from softgel capsules and tablets: a pilot study 2014 · tablet full-dose (four tablets) · Healthy adults aged 18–45 years, women and men | 452 mg | 1 day | 15 |
| Antioxidant Supplementation Protects Elite Athlete Muscle Integrity During Submaximal Training 2022 · antioxidant supplementation (AS) · Elite-level endurance athletes | 1 g | 6 weeks | 15 |
| Consumption of Nitrate-Rich Beetroot Juice with or without Vitamin C Supplementation Increases the Excretion of Urinary Nitrate, Nitrite, and N-nitroso Compounds in Humans 2019 · BRJ + VitC group · Healthy recreationally active men and women aged 18–45 | 1 g | 7 days | 14 |
| Antioxidant supplementation enhances neutrophil oxidative burst in trained runners following prolonged exercise 2003 · antioxidant vitamin supplement · Healthy trained endurance runners; 6 men and 6 women, mean age 30.1 years | 900 mg | 7 days | 12 |
| Nitrate and vitamin C from fruits and vegetables: impact of intake variations on nitrate and nitrite excretions of humans 1994 · 414 mg nitrate + nitrite and 23 mg vitamin C diet · Apparently healthy adults; age range and sex not reported | 23 mg | 7 days | 12 |
| Nitrate and vitamin C from fruits and vegetables: impact of intake variations on nitrate and nitrite excretions of humans 1994 · 412 mg nitrate + nitrite and 177 mg vitamin C diet · Apparently healthy adults; age range and sex not reported | 177 mg | 7 days | 12 |
| Nitrate and vitamin C from fruits and vegetables: impact of intake variations on nitrate and nitrite excretions of humans 1994 · 23 mg nitrate + nitrite and 39 mg vitamin C diet · Apparently healthy adults; age range and sex not reported | 39 mg | 7 days | 12 |
| Nitrate and vitamin C from fruits and vegetables: impact of intake variations on nitrate and nitrite excretions of humans 1994 · 21 mg nitrate + nitrite and 193 mg vitamin C diet · Apparently healthy adults; age range and sex not reported | 193 mg | 7 days | 12 |
| Effect of combined supplementation with alpha-tocopherol, ascorbate, and beta carotene on low-density lipoprotein oxidation 1993 · combined antioxidant therapy · adult male subjects; age and health condition not specified | 1 g | 90 days | 12 |
| Zinc supplementation prevents the increase of transaminase in chronic hepatitis C patients during combination therapy with pegylated interferon alpha-2b and ribavirin 2007 · zinc group · Patients with chronic hepatitis C receiving pegylated interferon alpha-2b and ribavirin therapy | 600 mg | 48 weeks | 11 |
| Protective effect of alpha-tocopherol and L-ascorbic acid against the ischemic-reperfusion injury in patients during open-heart surgery 1991 · Group 2 · Adults undergoing cardiopulmonary bypass for treatment of cardiac disease; age and sex not reported | 2 g | 1 day | 11 |
| Effects of supplementation of antioxidant vitamins and lipid peroxidation in critically ill patients 2013 · G2 · Critically ill patients; age and sex not reported | 600 mg | 8 days | 11 |
| Effect of nutrition intervention on antioxidant capacity and lipid peroxide in patients with bone marrow transplantation 2002 · experimental group · Bone marrow transplantation recipients; age and sex not reported | 300 mg | 15 days | 10 |
| Effects of antioxidant supplementation on blood cyclosporin A and glomerular filtration rate in renal transplant recipients 2005 · antioxidant supplementation phase · renal transplant recipients taking cyclosporin A; age and sex not reported | 500 mg | 26 weeks | 10 |
| Phototoxic lysis of erythrocytes from humans is reduced after oral intake of ascorbic acid and d-alpha-tocopherol 1997 · vitamins group · Human volunteers; age and sex not specified; no stated condition | 2 g | 7 days | 10 |
| Combined antioxidant treatment effects on blood oxidative stress after eccentric exercise 2005 · antioxidant supplement · Women aged 19–31 years who were not resistance-trained, undergoing eccentric elbow-flexor exercise | 1 g | 16 days | 9 |
| Short-Term High-Dose Vitamin C and E Supplementation Attenuates Muscle Damage and Inflammatory Responses to Repeated Taekwondo Competitions: A Randomized Placebo-Controlled Trial 2018 · Vitamin C and E supplement group (Vit C+E) · Elite male Taekwondo athletes, approximately 21 years old, competing at national or international level | 2 g | 4 days | 9 |
| Total radical-trapping antioxidant potential (TRAP) of plasma: effects of supplementation of young healthy volunteers with large doses of alpha-tocopherol and ascorbic acid 1993 · Group 4, alpha-tocopherol and ascorbic acid · Young healthy adults; age range and sex not reported | 1 g | 4 weeks | 8 |
| Supplementation with vitamins C and E inhibits the release of interleukin-6 from contracting human skeletal muscle 2004 · Treatment · Young healthy men | 500 mg | 4 weeks | 7 |
| Enhanced monocyte expression of tissue factor by oxidative stress in patients with antiphospholipid antibodies: effect of antioxidant treatment 2003 · antioxidant supplementation · 11 antiphospholipid antibody-positive patients | 2 g | 6 weeks | 6 |
| Antioxidants, but not B-group vitamins increase the resistance of low-density lipoprotein to oxidation: a randomized, factorial design, placebo-controlled trial 1999 · Antioxidant vitamins · Men aged 30–49 with plasma homocysteine concentration ≥8.34 μmol/L | 150 mg | 8 weeks | — |
| Effect of two years' supplementation with natural antioxidants on vitamin and trace element status biomarkers: preliminary data of the SU.VI.MAX study 2001 · Antioxidant supplementation group · Women aged 35–60 years and men aged 45–60 years in France, general population | 120 mg | 2 years | — |
| Diet supplementation with vitamin E, vitamin C and beta-carotene cocktail enhances basal neutrophil antioxidant enzymes in athletes 2002 · antioxidant-supplemented group · Sportsmen; age and health condition not specified | 1 g | 90 days | — |
| Effects of vitamin C and vitamin E on in vivo lipid peroxidation: results of a randomized controlled trial 2002 · vitamins C + E · nonsmokers | 500 mg | 60 days | — |
| Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function 2003 · group B [high dose of supplement] · Patients with cystic fibrosis; age and sex not specified | 300 mg | 8 weeks | — |
| Antioxidant vitamin supplementation in Crohn's disease decreases oxidative stress. a randomized controlled trial 2003 · vitamins E and C · Adults with stable, inactive or mildly active Crohn's disease and oxidative stress | 1 g | 4 weeks | — |
| Effects of antioxidant vitamins C and E on endothelial function and thrombosis/fibrinolysis system in smokers 2003 · group B · Healthy smokers; age range and sex not reported | 2 g | 4 weeks | — |
| Effects of antioxidant vitamins C and E on endothelial function and thrombosis/fibrinolysis system in smokers 2003 · group C · Healthy smokers; age range and sex not reported | 2 g | 4 weeks | — |
| Timing of antioxidant vitamin ingestion alters postprandial proatherogenic serum markers 2003 · Vitamins before breakfast · 11 people with type 2 diabetes | 1 g | 1 day | — |
| Timing of antioxidant vitamin ingestion alters postprandial proatherogenic serum markers 2003 · Vitamins before supper · 11 people with type 2 diabetes | 1 g | 1 day | — |
| Changes in serum retinol, alpha-tocopherol, vitamin C, carotenoids, xinc and selenium after micronutrient supplementation during alcohol rehabilitation 2003 · micronutrient supplement group · Alcohol-dependent patients aged 20 to 60 years without severe liver disease, hospitalized for alcohol rehabilitation | 120 mg | 3 weeks | — |
| Antioxidant vitamins decrease exercise-induced QT dispersion after myocardial infarction 2003 · vitamin C and E · Patients with acute myocardial infarction; age and sex not specified | 600 mg | 2 weeks | — |
| Effects of combined administration of vitamins C and E on reactive hyperemia and inflammatory process in chronic smokers 2003 · group B · Healthy young chronic smokers; age and sex not specified | 2 g | 4 weeks | — |
| Effects of combined administration of vitamins C and E on reactive hyperemia and inflammatory process in chronic smokers 2003 · group C · Healthy young chronic smokers; age and sex not specified | 2 g | 4 weeks | — |
| Antioxidant diet supplementation influences blood iron status in endurance athletes 2004 · antioxidant supplemented · Amateur trained male endurance athletes | 1 g | 90 days | — |
| Antioxidant supplementation and nasal inflammatory responses among young asthmatics exposed to high levels of ozone 2004 · vitamin supplement group · Children with asthma living in Mexico City | 250 mg | 120 days | — |
| Antioxidant vitamin supplementation reduces benzo(a)pyrene-DNA adducts and potential cancer risk in female smokers 2005 · antioxidant vitamin supplementation · smokers who smoked at least 10 cigarettes per day and had serum cotinine of at least 25 ng/mL; both men and women enrolled | 500 mg | 456 days | — |
| Effects of vitamins C and E on oxidative stress markers and endothelial function in patients with systemic lupus erythematosus: a double blind, placebo controlled pilot study 2005 · vitamin-treated group · Patients with systemic lupus erythematosus (SLE); age and sex not stated | 500 mg | 12 weeks | — |
| Reduction of the incidence of sperm DNA fragmentation by oral antioxidant treatment 2005 · antioxidant treatment group · Men with unexplained infertility and at least 15% DNA-fragmented spermatozoa in the ejaculate | 1 g | 60 days | — |
| Response of blood cell antioxidant enzyme defences to antioxidant diet supplementation and to intense exercise 2006 · antioxidant supplemented · Amateur trained male athletes; age and health condition not specified | 1 g | 90 days | — |
| Vitamin E isoform-specific inhibition of the exercise-induced heat shock protein 72 expression in humans 2006 · CEalpha · Young men | 500 mg | 4 weeks | — |
| Vitamin E isoform-specific inhibition of the exercise-induced heat shock protein 72 expression in humans 2006 · CEalphagamma · Young men | 500 mg | 4 weeks | — |
| Short-term daily or weekly administration of micronutrient Sprinkles has high compliance and does not cause iron overload in Chinese schoolchildren: a cluster-randomised trial 2006 · daily group · Children aged 3–6 years in a kindergarten in northern China | 50 mg | 13 weeks | — |
| A randomized factorial study of the effects of long-term garlic and micronutrient supplementation and of 2-wk antibiotic treatment for Helicobacter pylori infection on serum cholesterol and lipoproteins 2006 · micronutrient supplementation · Disease-free people in a rural Chinese population; age and sex not specified | 500 mg | 2666 days | — |
| Antioxidant supplementation lowers exercise-induced oxidative stress in young overweight adults 2006 · overweight adults receiving antioxidant treatment · overweight adults aged 18–30 years | 500 mg | 8 weeks | — |
| Antioxidant supplementation lowers exercise-induced oxidative stress in young overweight adults 2006 · normal-weight adults receiving antioxidant treatment · normal-weight adults aged 18–30 years | 500 mg | 8 weeks | — |
| Multivitamin-mineral supplementation prevents lipid peroxidation during "the Marathon des Sables" 2007 · Supplemented group · Athletes participating in the Marathon des Sables; age and sex not specified | 150 mg | 4 weeks | — |
| Antioxidant diet supplementation enhances aerobic performance in amateur sportsmen 2007 · antioxidant-supplemented group · Amateur male athletes; age and health condition not stated | 1 g | 90 days | — |
| Gender comparisons of exercise-induced oxidative stress: influence of antioxidant supplementation 2007 · antioxidant (A) · Men and women who ran for 30 minutes at 80% VO2 max; ages and health conditions not stated | 1 g | 2 weeks | — |
| Inflammatory response to a high-fat, low-carbohydrate weight loss diet: effect of antioxidants 2008 · antioxidant supplement (AS) · Overweight adults with BMI >27 kg/m²; age and sex not specified | 1 g | 7 days | — |
| Influence of an antioxidant vitamin-enriched drink on pre- and post-exercise lymphocyte antioxidant system 2008 · antioxidant supplementation · Male amateur trained runners aged 32–36 years | 152 mg | 30 days | — |
| [Study the effect of antioxidant vitamin E, vitamin C and beta-carotene supplement on erythrocyte functions in elderly person] 2008 · Group 1 · Adults aged 60–75 years; elderly participants | 300 mg | 16 weeks | — |
| [Study the effect of antioxidant vitamin E, vitamin C and beta-carotene supplement on erythrocyte functions in elderly person] 2008 · Group 2 · Adults aged 60–75 years; elderly participants | 300 mg | 16 weeks | — |
| [Study the effect of antioxidant vitamin E, vitamin C and beta-carotene supplement on erythrocyte functions in elderly person] 2008 · Group 3 · Adults aged 60–75 years; elderly participants | 300 mg | 16 weeks | — |
| Effects of antioxidant supplementation on insulin sensitivity, endothelial adhesion molecules, and oxidative stress in normal-weight and overweight young adults 2009 · Normal-weight antioxidant-treated (N-AOX) · Apparently healthy men and women aged 18–30 years with BMI <25 kg/m² | 500 mg | 8 weeks | — |
| Effects of antioxidant supplementation on insulin sensitivity, endothelial adhesion molecules, and oxidative stress in normal-weight and overweight young adults 2009 · Overweight antioxidant-treated (O-AOX) · Apparently healthy men and women aged 18–30 years with BMI ≥25 kg/m² | 500 mg | 8 weeks | — |
| Serum vaspin concentrations are decreased after exercise-induced oxidative stress 2010 · antioxidant supplementation · healthy young men after a standardized 4-week physical training program | 1 g | 4 weeks | — |
| Antioxidant therapy reduces oxidative and inflammatory tissue damage in patients subjected to cardiac surgery with extracorporeal circulation 2011 · n-3 PUFA plus antioxidant vitamins · Either-sex patients undergoing on-pump cardiac surgery | 1 g | — | — |
| Antioxidant therapy reduces oxidative and inflammatory tissue damage in patients subjected to cardiac surgery with extracorporeal circulation 2011 · Antioxidant vitamins C and E without n-3 PUFA · Either-sex patients undergoing on-pump cardiac surgery | 1 g | — | — |
| Effect of mixed flavonoids, n-3 fatty acids, and vitamin C on oxidative stress and antioxidant capacity before and after intense cycling 2011 · QFO · Athletes; age and sex not specified | 1 g | 17 days | — |
| Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures 2012 · E/C/ALA · Adults aged 50–85 with probable Alzheimer disease and MMSE scores of 16 or more | 500 mg | 16 weeks | — |
| Dose-response to 3 months of quercetin-containing supplements on metabolite and quercetin conjugate profile in adults 2013 · Q-1000 · Healthy adults aged 40–83 years; women and men | 250 mg | 90 days | — |
| Dose-response to 3 months of quercetin-containing supplements on metabolite and quercetin conjugate profile in adults 2013 · Q-500 · Healthy adults aged 40–83 years; women and men | 125 mg | 90 days | — |
| Prevention of neutrophil protein oxidation with vitamins C and E diet supplementation without affecting the adaptive response to exercise 2013 · antioxidant supplementation · Trained male amateur runners | 152 mg | 30 days | — |
| Modulation of (Na,K)-ATPase activity by membrane fatty acid composition: therapeutic implications in human hypertension 2014 · vitamin C + E · Men with essential hypertension; age range not reported | 1 g | 8 weeks | — |
| Antioxidant supplements reduced oxidative stress and stabilized liver function tests but did not reduce inflammation in a randomized controlled trial in obese children and adolescents 2014 · antioxidant supplementation · Overweight or obese children and adolescents; mean age 12.7 ± 1.5 years | 500 mg | 120 days | — |
| Antioxidants may Attenuate Plasma Erythropoietin Decline after Hyperbaric Oxygen Diving 2015 · vitamin group · healthy male police task force divers exposed to repeated hyperbaric oxygen diving | 1 g | 3 days | — |
| Vitamin C and E supplementation prevents some of the cellular adaptations to endurance-training in humans 2015 · antioxidant group · healthy young males | 1 g | 8 weeks | — |
| Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration 2025 · AREDS antioxidants only · Adults aged 55–80 with early or more advanced age-related macular degeneration | 500 mg | 5 years | — |
| Lipid peroxidation and antioxidative vitamins under extreme endurance stress 1994 · Supplemented group · Trained long-distance runners; age and sex not reported | 200 mg | 32 days | — |
| Effects of an antioxidant vitamin mixture on lipid peroxidation at rest and postexercise 1993 · antioxidant vitamin group · Young healthy males, mean age 25.0 years | 1 g | 6 weeks | — |
| Antioxidants, Helicobacter pylori and stomach cancer in Venezuela 1996 · Treatment 2 · People with precancerous stomach lesions, including chronic gastritis, chronic atrophic gastritis, intestinal metaplasia or dysplasia; age and sex not specified | 650 mg | 7 days | — |
| Effect of 6 month supplementation with different combinations of an association of antioxidant nutrients on biochemical parameters and markers of the antioxidant defence system in the elderly. The Geriatrie/Min.Vit.Aox Network 1996 · VT (vitamins associated with trace elements) · Elderly nursing-home residents aged 65–103 years who were long-term hospitalized | 120 mg | 26 weeks | — |
| Modulation of oxidant stress in vivo in chronic cigarette smokers 1996 · vitamin C and vitamin E combination · Chronic cigarette smokers; age and sex not reported | 2 g | 5 days | — |
| Weekly micronutrient supplementation to build iron stores in female Indonesian adolescents 1997 · daily supplementation group · female Indonesian high-school adolescents | 60 mg | 90 days | — |
| Weekly micronutrient supplementation to build iron stores in female Indonesian adolescents 1997 · weekly supplementation group (60 mg Fe) · female Indonesian high-school adolescents | 8.57 mg | 90 days | — |
| Weekly micronutrient supplementation to build iron stores in female Indonesian adolescents 1997 · weekly supplementation group (120 mg Fe) · female Indonesian high-school adolescents | 8.57 mg | 90 days | — |
| Antioxidant nutrient supplementation reduces the susceptibility of low density lipoprotein to oxidation in patients with coronary artery disease 1997 · mid-dose · Patients with established cardiovascular disease | 500 mg | 12 weeks | — |
| Antioxidant nutrient supplementation reduces the susceptibility of low density lipoprotein to oxidation in patients with coronary artery disease 1997 · high dose · Patients with established cardiovascular disease | 1 g | 12 weeks | — |
| Effect of a two-year supplementation with low doses of antioxidant vitamins and/or minerals in elderly subjects on levels of nutrients and antioxidant defense parameters 1997 · mineral and vitamin group · Hospitalized adults older than 65 years; baseline deficiencies of vitamin C, zinc and selenium were common | 120 mg | 2 years | — |
| Effects of trace element and/or vitamin supplementation on vitamin and mineral status, free radical metabolism and immunological markers in elderly long term-hospitalized subjects. Geriatric Network MIN. VIT. AOX 1997 · trace elements associated with vitamins · Institutionalized elderly subjects in long-term hospital or nursing-home care | 120 mg | 1 year | — |
| Effects of supplementation with a combination of antioxidant vitamins and trace elements, at nutritional doses, on biochemical indicators and markers of the antioxidant system in adult subjects 1998 · supplementation group · Adult men aged 45–60 years and women aged 35–60 years | 120 mg | 26 weeks | — |
| Effects of omega-3 fatty acids and/or antioxidants on endothelial cell markers 1998 · antioxidants without n-3 fatty acids · adult male smokers with hyperlipidaemia | 150 mg | 6 weeks | — |
| Micronutrient Sprinkles reduce anemia among 9- to 24-mo-old children when delivered through an integrated health and nutrition program in rural Haiti 2007 · Sprinkles-WSB (S-WSB) · Children aged 9–24 months in rural Haiti receiving take-home fortified wheat-soy blend rations | 30 mg | 60 days | 254 |
| Usefulness of antioxidant vitamins in suspected acute myocardial infarction (the Indian experiment of infarct survival-3) 1996 · intervention group · Patients with suspected acute myocardial infarction; age and sex not stated | 1 g | 4 weeks | 63 |
| Efficacy and safety of emulsified microsomal ferric pyrophosphate vs. Ferrous Ascorbate in pregnancy with iron-deficiency anemia- a randomized, comparative study 2025 · Group A (test) · Pregnant women aged 20–35 years, at 13–16 weeks’ gestation, with iron-deficiency anemia (hemoglobin 9–10.5 g/dL and serum ferritin <15 mcg/L) | 50 mg | 4 weeks | 55 |
| Effect of daily and weekly micronutrient supplementation on micronutrient deficiencies and growth in young Vietnamese children 1999 · daily group · children aged 6–24 months in Vietnam | 20 mg | 90 days | 55 |
| Effect of daily and weekly micronutrient supplementation on micronutrient deficiencies and growth in young Vietnamese children 1999 · weekly group · children aged 6–24 months in Vietnam | 2.86 mg | 90 days | 54 |
| Folate levels determine effect of antioxidant supplementation on micronuclei in subjects with cardiovascular risk 2004 · antioxidant-supplemented group · Middle-aged men: myocardial infarction survivors younger than 50 and healthy controls | 100 mg | 12 weeks | 53 |
| Antioxidant micronutrients improve intrinsic and UV-induced apoptosis of human lymphocytes particularly in elderly people 2011 · Y2 · Healthy young adults aged 18–22 years | 500 mg | 60 days | 45 |
| Antioxidant micronutrients improve intrinsic and UV-induced apoptosis of human lymphocytes particularly in elderly people 2011 · O2 · Healthy older adults aged 60–75 years | 500 mg | 60 days | 45 |
| [Effect of multiple micronutrients supplementation on anti-oxidative activity and oxidized DNA damage of lymphocytes in children] 2005 · supplement group · Chinese children aged 9–11 years, described as healthy and living in a rural area | 300 mg | 8 weeks | 41 |
| Antioxidant micronutrients improve intrinsic and UV-induced apoptosis of human lymphocytes particularly in elderly people 2011 · C2 · Healthy children aged 8–10 years | 300 mg | 60 days | 40 |
| Effects of antioxidant supplementation on platelet function: a randomized pair-matched, placebo-controlled, double-blind trial in men with low antioxidant status 1991 · antioxidant-supplemented men · Men with low antioxidant status | 600 mg | 150 days | 39 |
| Use of Nutraceuticals in Elderly to Fight Inflammation and Immuno-Senescence: A Randomized Case-Control Study 2022 · TG1 · Hospitalized adults older than 65 years; sex not restricted; recruited for causes other than cancer, with specified immune-disease and infection exclusions | 135 mg | 12 weeks | 30 |
| Use of Nutraceuticals in Elderly to Fight Inflammation and Immuno-Senescence: A Randomized Case-Control Study 2022 · TG2 · Hospitalized adults older than 65 years; sex not restricted; recruited for causes other than cancer, with specified immune-disease and infection exclusions | 270 mg | 6 weeks | 30 |
| A Mixed Flavonoid-Fish Oil Supplement Induces Immune-Enhancing and Anti-Inflammatory Transcriptomic Changes in Adult Obese and Overweight Women-A Randomized Controlled Trial 2016 · Q-Mix · Women aged 40–70 years who were overweight or obese (BMI ≥25 kg/m²), without the listed major diseases | 500 mg | 10 weeks | 24 |
| Cardiovascular disease-risk factors in middle-aged osteopaenic women treated with calcium alone or combined to three nutrients essential to artery and bone collagen 2008 · group C · Middle-aged women with low bone mineral density (osteopaenia) | 500 mg | 1 year | 20 |
| Increase in oxidation resistance of atherogenic serum lipoproteins following antioxidant supplementation: a randomized double-blind placebo-controlled clinical trial 1994 · supplemented group · Healthy men aged 30–58 years who smoked 15–40 cigarettes per day | 400 mg | 90 days | 20 |
| Comparison of the effects of vitamins and/or mineral supplementation on glomerular and tubular dysfunction in type 2 diabetes 2005 · group MV · Patients with type 2 diabetes; age range and sex not specified | 200 mg | 90 days | 17 |
| Lutein Complex Supplementation Increases Ocular Blood Flow Biomarkers in Healthy Subjects 2019 · lutein phytochemicals complex · Healthy women, mean age 36.8 ± 12.1 years | 500 mg | 3 weeks | 16 |
| Oxidative stress in humans during work at moderate altitude 1999 · antioxidant mixture group · U.S. Marines engaged in moderate-altitude cold-weather field training; age and sex not reported | 500 mg | 4 weeks | 15 |
| Multinutrient Supplementation Increases Collagen Synthesis during Early Wound Repair in a Randomized Controlled Trial in Patients with Inguinal Hernia 2020 · multinutrient group · Men scheduled for Lichtenstein inguinal hernia repair; mean age 55.2 years, with inguinal hernia disease | 1.25 g | 4 weeks | 10 |
| Antioxidant supplementation and tapering exercise improve exercise-induced antioxidant response 2003 · supplemented group (Su) · Triathletes; age, sex and health status not specified | 120 mg | 6 weeks | 7 |
| Antioxidant supplementation preserves antioxidant response in physical training and low antioxidant intake 2004 · supplemented (S) group · Overloaded triathletes with initially low antioxidant intakes | 120 mg | 8 weeks | 7 |
| Antioxidants, but not B-group vitamins increase the resistance of low-density lipoprotein to oxidation: a randomized, factorial design, placebo-controlled trial 1999 · B vitamins with antioxidant vitamins · Men aged 30–49 with plasma homocysteine concentration ≥8.34 μmol/L | 150 mg | 8 weeks | — |
| Effect of antioxidant supplementation on urine and blood markers of oxidative stress during extended moderate-altitude training 1999 · antioxidant supplement (S) group · US Marine Corps volunteers undergoing 14 days of winter training at approximately 2700 m | 500 mg | 2 weeks | — |
| Inhibition of tumour necrosis factor-alpha and interleukin 6 production by mononuclear cells following dietary fish-oil supplementation in healthy men and response to antioxidant co-supplementation 2003 · Antioxidant co-supplement group · Healthy men | 90 mg | 12 weeks | — |
| Prostaglandin E2 production and T cell function after fish-oil supplementation: response to antioxidant cosupplementation 2003 · Antioxidant cosupplementation group · Healthy men; age not stated | 90 mg | 12 weeks | — |
| Plasma C-reactive protein concentrations in active and passive smokers: influence of antioxidant supplementation 2004 · antioxidant mixture · Healthy adult men and women who were active or passive smokers | 515 mg | 60 days | — |
| Alterations of the lipid profile after 7.5 years of low-dose antioxidant supplementation in the SU.VI.MAX Study 2005 · antioxidant supplementation · French adults: women aged 35–60 years and men aged 45–60 years | 120 mg | 2738 days | — |
| Effects of long-term zinc supplementation on plasma thiol metabolites and redox status in patients with age-related macular degeneration 2007 · antioxidants plus zinc · Adults aged 55–80 with age-related macular degeneration | 500 mg | 2433 days | — |
| Antioxidant micronutrients and biomarkers of oxidative stress and inflammation in colorectal adenoma patients: results from a randomized, controlled clinical trial 2010 · antioxidant micronutrient combination · Patients with a history of sporadic colorectal adenoma; age and sex not specified | 1 g | 120 days | — |
| Effects of 6 weeks of n-3 fatty acids and antioxidant mixture on lipid peroxidation at rest and postexercise 2011 · LCPUFA plus antioxidant mixture · Judoists; age and sex not reported; no diagnosed condition stated | 60 mg | 6 weeks | — |
| Antioxidant micronutrient supplementation increases erythrocyte membrane fluidity in adults from a rural Chinese community 2011 · A2 · Children; age range and sex not reported | 300 mg | 60 days | — |
| Antioxidant micronutrient supplementation increases erythrocyte membrane fluidity in adults from a rural Chinese community 2011 · B2 · Young people; age range and sex not reported | 500 mg | 60 days | — |
| Antioxidant micronutrient supplementation increases erythrocyte membrane fluidity in adults from a rural Chinese community 2011 · C2 · Elderly subjects; age range and sex not reported | 500 mg | 60 days | — |
| Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration 2025 · AREDS antioxidants plus zinc · Adults aged 55–80 with early or more advanced age-related macular degeneration | 500 mg | 5 years | — |
| Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration 2025 · AREDS2 original AREDS formulation · Adults aged 50–85 with large drusen in both eyes or late AMD in one eye and large drusen in the fellow eye who accepted the additional AREDS formulation | 500 mg | 5 years | — |
| Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration 2025 · AREDS2 original AREDS formulation without β-carotene · Adults aged 50–85 with large drusen in both eyes or late AMD in one eye and large drusen in the fellow eye who accepted the additional AREDS formulation | 500 mg | 5 years | — |
| Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration 2025 · AREDS2 original AREDS formulation with low zinc · Adults aged 50–85 with large drusen in both eyes or late AMD in one eye and large drusen in the fellow eye who accepted the additional AREDS formulation | 500 mg | 5 years | — |
| Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration 2025 · AREDS2 original AREDS formulation without β-carotene and with low zinc · Adults aged 50–85 with large drusen in both eyes or late AMD in one eye and large drusen in the fellow eye who accepted the additional AREDS formulation | 500 mg | 5 years | — |
| Peroxidation of LDL from combined-hyperlipidemic male smokers supplied with omega-3 fatty acids and antioxidants 1997 · antioxidants · male smokers with combined hyperlipidemia | 150 mg | 6 weeks | — |
| Peroxidation of LDL from combined-hyperlipidemic male smokers supplied with omega-3 fatty acids and antioxidants 1997 · omega-3 FAs and antioxidants · male smokers with combined hyperlipidemia | 150 mg | 6 weeks | — |
| Effects of omega-3 fatty acids and/or antioxidants on endothelial cell markers 1998 · n-3 fatty acids with antioxidants · adult male smokers with hyperlipidaemia | 150 mg | 6 weeks | — |
| Does combined antioxidant vitamin supplementation blunt repeated bout effect? 2015 · supplement (S) group · moderately trained males | 1 g | 2 weeks | — |
| Supplementation with antioxidants prior to bone marrow transplantation 1997 · Healthy control group · Healthy controls | 450 mg | 3 weeks | 10 |
| GLV supplements increased plasma beta-carotene, vitamin C, zinc and hemoglobin in young healthy adults 2006 · GLV with vitamin C · Young adults; sex, age range and health condition not reported | 100 mg | 3 weeks | — |
| Effects of long-term zinc supplementation on plasma thiol metabolites and redox status in patients with age-related macular degeneration 2007 · antioxidants · Adults aged 55–80 with age-related macular degeneration | 500 mg | 2433 days | — |
| Effects of collagen tripeptide supplement on skin properties: a prospective, randomized, controlled study 2014 · Group D · Healthy volunteers; age and sex not specified | 500 mg | 12 weeks | — |
| Low-dose B vitamins supplementation ameliorates cardiovascular risk: a double-blind randomized controlled trial in healthy Chinese elderly 2015 · control group · Healthy adults aged 60–74 years | 50 mg | 1 year | — |